"URL","Uniprot ID","PMID","Abstract"
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,27729462,"Our findings suggest that there are interaction effects of DM and SCN10A (rs7375036) that influence the development of CAN."
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,27598514,"The p.M650K mutation shifted steady-state fast inactivation of Nav1.8 (SCN10A)to more hyperpolarized potentials and did not significantly alter any other tested gating behaviors. The AP half-width was significantly broader and the stimulated action potential firing rate was reduced for M650K transfected DRGs compared to WT."
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,27590072,"This study demonstrated that at the association and mechanistic levels, the SCN10A single nucleotide polymorphism rs6795970 biases human pain sensitivity."
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,27272739,"We investigated the association of SCN10A gene variants with 105 sporadic sudden unexplained nocturnal death syndrome victims.  A total of 6 rare mutations and 16 polymorphisms were detected in SUNDS victims. This is the first report of common and rare variants of SCN10A gene in the Chinese Han population, which provides the genetic epidemiological evidence that SCN10A may be a novel susceptibility gene."
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,26740675,"SCN10A genetic variation substantially influences functional status in patients with multiple sclerosis."
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,26733327,"SCN10A mutations do not play primary role in arrhythmogenic right ventricular dysplasia/cardiomyopathy."
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,26104176,"The rs6795970 in the SCN10A gene, which is reported to carry a high risk of heart block, might be associated with cardiac conduction abnormalities in Hypertrophic Cardiomyopathy patients."
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,25998140,"SCN10A gene mutations that reduce sodium channel current may provide a mechanistic link between Atrioventricular nodal reentrant tachycardia and Brugada syndrome and predispose to expression of both phenotypes."
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,25842276,"Compared with Brugada syndrome (BrS) patients carrying SCN5A or CACNA1C mutations, symptomatic patients in the SCN10A group tended to be older than those in the other gene groups. In six BrS probands who carried SCN10A variants, most experienced severe arrhythmic attacks."
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,25787950,"The results demonstrate distinct properties of human Na(v)1.8, which contribute to the firing properties of human DRG neurons."
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,25691686,"study suggests that SCN10A variations are involved in the genesis of AF."
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,25691538,"The common SNP SCN10A V1073 was strongly associated with Brugada syndrome and demonstrated loss of NaV1.8 function, as did rare variants in isolated patients."
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,25053638,"Rare SCN10A variants may contribute to atrial fibrillation susceptibility."
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,24998131,"As a major susceptibility gene for Brugada syndrome (BrS), SCN10A greatly enhances the genotyping and risk stratifying of probands and BrS family members."
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,24763188,"A novel splice variant of SCN10A lacking exon 11 was found in human but not detected in mouse or rat."
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,24642470,"SCN10A variant rs6801957, which correlated with slowed cardiac conduction, was associated with reduced SCN5A expression."
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,24360055,"A single-nucleotide polymorphism (SNP) associated with alterations in cardiac conduction patterns affects the transcriptional regulation of the sodium channel genes, SCN5A and SCN10A, predisposing for cardiac arrhythmias."
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,24144460,"The results demonstrate that Nav1.8 and Nav1.9 are present in human lingual nerve neuromas, with significant correlations between the level of expression of Nav1.8 and symptoms of pain."
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,24086692,"Results verify that the Na+ channel Na v1.8 is present in human sperm cells and participates in the regulation of sperm function."
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,24072447,"SCN10A SNPs modulate PR interval and heart rate response during atrial fibrillation."
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,24006052,"This study reports a mutation of NaV1.8 which impairs inactivation, in patients with painful idiopathic small fibre neuropathy."
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,23986244,"I1706V mutation associated with small-fiber neuropathy decreases current threshold and increases the firing frequency of evoked action potentials within small DRG neurons."
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,23872634,"Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death."
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,23115331,"Mutations of Na(v)1.8 contribute to painful peripheral neuropathy."
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,23047628,"Single nucleotide polymorphism of TRPV1 315G>C, rs5981521 of pri-miR-325 and SCN10A is related to the development of functional dyspepsia. This involvement differed between Helicobater pylori-positive and -negative patients."
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,22618805,"We found that SCN10A 3218 CC homozygosity with the 2884 G and 3275 C alleles was significantly associated with a reduced risk for the development of functional dyspepsia."
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,21646736,"sodium channel Na(v)1.8 is present in sensory nerves and cardiomyocytes of human heart"
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,21076409,"Observational study, meta-analysis, and genome-wide association study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,21041692,"Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,20720009,"Transmembrane segments prevent surface expression of sodium channel Nav1.8 and promote calnexin-dependent channel degradation"
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,20379614,"Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,20237269,"Ret-Na(v)1.8 conditional knockout mice have increased sensitivity to cold and increased formalin-induced pain, demonstrating that Ret signaling modulates the function of nociceptors in vivo."
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,20062063,"Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,20062061,"SCN10A is expressed in mouse and human heart tissue and that PR interval is shorter in Scn10a(-/-) mice than in wild-type mice."
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,20062061,"Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,20062060,"Meta-analysis and genome-wide association study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,20018876,"Aquaporin-1 tunes pain perception by interaction with Na(v)1.8 Na+ channels in dorsal root ganglion neurons."
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,19953341,"Data describe alternative splicing in a NAGNAG tandem acceptor in SCN10A that results in isoforms including/lacking glutamine 1030, which is conserved among rodents and humans but its alternative usage apparently occurs with species-specific abundance."
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,19877286,"Nav1.8 downregulation may be one of the pathophysiological mechanisms involved in limb lengthening-induced neuropathy."
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,19699781,"In trigeminal neuralgia (TN) there is a reduction in the expression of Nav1.7 and an increase in the expression of Nav1.3, Nav1.8 expression not significantly different; TN can be, at least in part, a channelopathy."
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,19563686,"activation of NK-1 receptor potentiates Na(v)1.8 sodium current via PKCepsilon-dependent signaling pathway, probably participating in the generation of inflammatory hyperalgesia"
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,19233853,"Data suggest differing, but partially overlapping, areas of binding of A-803467 and tetracaine in the Na(V)1.8 sodium channel."
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,19164297,"Chimeras containing the N-terminal half of Na(v)1.8 exhibited a large response similar to wild-type Na(v)1.8, indicating that the region conferring high sensitivity to ciguatoxin action is located in the D1 or D2 domains."
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,16598065,"calmodulin associates with a sodium channel, Nav1.8, in native neurons, and demonstrates a regulation of Nav1.8 currents that can significantly affect electrogenesis of DRG neurons in which Nav1.8 is normally expressed"
https://pharos.nih.gov/idg/targets/Q9Y5Y9,Q9Y5Y9,16506887,"A high capacity assay is sensitive to known state-dependent NaV1 modulators and can be used to identify novel and selective inhibitors."
https://pharos.nih.gov/idg/targets/Q9NY46,Q9NY46,27153334,"Data indicate eight new cases with overlapping duplications at 2q24 and SCN3A was not involved in duplication, suggesting that having an extra copy of SCN2A has an effect on epilepsy pathogenesis."
https://pharos.nih.gov/idg/targets/Q9NY46,Q9NY46,27072680,"sodium channel currents in oocytes expressing either wild-type or mutant (A4V) SOD1 protein"
https://pharos.nih.gov/idg/targets/Q9NY46,Q9NY46,24337656,"sodium channel polymorphisms are associated with epilepsy"
https://pharos.nih.gov/idg/targets/Q9NY46,Q9NY46,24157691,"Discovery of a common biophysical defect among variants identified in unrelated pediatric epilepsy patients suggests that SCN3A may contribute to neuronal hyperexcitability and epilepsy."
https://pharos.nih.gov/idg/targets/Q9NY46,Q9NY46,23965409,"the time course of declining expression of the murine embryonic sodium channel Nav 1.3 and the rise in expression of the adult sodium channel Nav 1.1 with susceptibility to epileptic seizures and increased incidence of sudden death"
https://pharos.nih.gov/idg/targets/Q9NY46,Q9NY46,23859570,"Our data from the Hong Kong and Malaysia cohorts showed no significant allele, genotype and haplotype association of polymorphisms in the SCN1A, SCN2A, and SCN3A genes with drug responsiveness in epilepsy."
https://pharos.nih.gov/idg/targets/Q9NY46,Q9NY46,23333304,"HIV-1 Vif downregulates the expression of sodium channel, voltage-gated, type III, alpha subunit (SCN3A) in Vif-expression T cells"
https://pharos.nih.gov/idg/targets/Q9NY46,Q9NY46,23016767,"This study demonistrated that associated with a duplication of the SCN2A and SCN3A gene cluster on 2q24 in patient with early onset epilepsy."
https://pharos.nih.gov/idg/targets/Q9NY46,Q9NY46,22494998,"Upregulation of Nav1.3 protein and a specific cellular distribution of Nav1.3 proteins in focal cortical dysplasia type IIb(FCDIIb) lesion tissue samples suggest that Nav1.3 may be involved in the generation of epileptic activity in FCDIIb."
https://pharos.nih.gov/idg/targets/Q9NY46,Q9NY46,20379614,"Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9NY46,Q9NY46,20346423,"Deletions in SCN3A gene is associated with autistic features and developmental delay."
https://pharos.nih.gov/idg/targets/Q9NY46,Q9NY46,19699781,"In trigeminal neuralgia (TN) there is a reduction in the expression of Nav1.7 and an increase in the expression of Nav1.3, Nav1.8 expression not significantly different; TN can be, at least in part, a channelopathy."
https://pharos.nih.gov/idg/targets/Q9NY46,Q9NY46,18784617,"The association of antiepileptic drugs responsiveness with genetic polymorphisms was investigated and any association with mRNA expression of the neuronal sodium channels was correlated."
https://pharos.nih.gov/idg/targets/Q9NY46,Q9NY46,18784617,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9NY46,Q9NY46,17544618,"Characterization of 5' untranslated regions SCN3A, and identification of cis-conserved noncoding sequences."
https://pharos.nih.gov/idg/targets/Q9NY46,Q9NY46,12610651,"in autism families, two polymorphic coding variants of SCN3A are described"
https://pharos.nih.gov/idg/targets/Q9UI33,Q9UI33,28953656,"SCN11A single-nucleotide polymorphisms affect Postoperative pain sensitivity in Chinese Han women after Gynecological surgery. The SNP rs33985936 and rs13080116 may serve as novel predictors for Postoperative pain."
https://pharos.nih.gov/idg/targets/Q9UI33,Q9UI33,28530638,"a U-shaped relationship between the resting potential and the neuronal action potential threshold explains why NaV1.9 mutations that evoke small degrees of membrane depolarization cause hyperexcitability and familial episodic pain disorder or painful neuropathy, while mutations evoking larger membrane depolarizations cause hypoexcitability and insensitivity to pain."
https://pharos.nih.gov/idg/targets/Q9UI33,Q9UI33,28298626,"We identified a missense mutation of p.Arg225Cys in SCN11A in a four-generation Chinese family with early-onset familial episodic pain and adult onset familial essential tremor syndrome."
https://pharos.nih.gov/idg/targets/Q9UI33,Q9UI33,27297039,"Results show the expression of Nav1.9 channels within the human colon for the first time. Furthermore, Nav1.9 channel expression is decreased in Hirschsprung's disease versus normal controls."
https://pharos.nih.gov/idg/targets/Q9UI33,Q9UI33,27224030,"Recently Nav1.9, a voltage-gated sodium channel subtype, has been established as a genetic influence for certain peripheral pain syndromes."
https://pharos.nih.gov/idg/targets/Q9UI33,Q9UI33,26746779,"autosomal dominant Congenital insensitivity to pain reflects the second gain-of-function mutation of SCN11A."
https://pharos.nih.gov/idg/targets/Q9UI33,Q9UI33,26645915,"A missense mutation (p.V1184A) in NaV1.9 leads to cold-aggravated peripheral pain."
https://pharos.nih.gov/idg/targets/Q9UI33,Q9UI33,25791876,"A G699R substitution in the Nav1.9 domain II S4-S5 linker renders dorsal root ganglion neurons hyperexcitable, via depolarized resting membrane potential, reduced current threshold and increased evoked firing in small-fiber neuropathy."
https://pharos.nih.gov/idg/targets/Q9UI33,Q9UI33,24776970,"missense mutations of Nav1.9 in individuals with painful peripheral neuropathy"
https://pharos.nih.gov/idg/targets/Q9UI33,Q9UI33,24207120,"Gain-of-function mutations in SCN11A can be causative of an autosomal-dominant episodic pain disorder."
https://pharos.nih.gov/idg/targets/Q9UI33,Q9UI33,24144460,"The results demonstrate that Nav1.8 and Nav1.9 are present in human lingual nerve neuromas, with significant correlations between the level of expression of Nav1.8 and symptoms of pain."
https://pharos.nih.gov/idg/targets/Q9UI33,Q9UI33,24036948,"we identified a specific de novo missense mutation in SCN11A in individuals with the congenital inability to experience pain who suffer from recurrent tissue damage and severe mutilations."
https://pharos.nih.gov/idg/targets/Q9UI33,Q9UI33,21857998,"Results provide evidence that Nav1.9 plays a crucial role in the generation of heat and mechanical pain hypersensitivity, both in subacute and chronic inflammatory pain models."
https://pharos.nih.gov/idg/targets/Q9UI33,Q9UI33,12384689,"we demonstrate that the tetrodotoxin-insensitive sodium channel Na(V)1.9 underlies the neurotrophin-evoked excitation"
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,28923014,"SCN8A mutation is not only associated with epileptic encephalopathy, but also can be the pathogenic cause of some benign phenotypes, such as BFIS/ICCA, especially the inherited mutations."
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,28518218,"Pathogenic, likely pathogenic, and benign variants in SCNs were identified using databases of sodium channel variants. Benign variants were also identified from population-based databases. Eight algorithms commonly used to predict pathogenicity were compared. In addition, logistic regression was used to determine if a combination of algorithms could better predict pathogenicity."
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,27875746,"Study reports several novel variants in SCN8A that were identified by gene panel analysis in patients with epilepsy and other neurodevelopmental disorders. The predominant pathogenic mechanism appears to involve disruption of channel inactivation, leading to gain-of-function effects."
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,27375106,"This study demonstrated that SCN8A - I1327V is a gain-of-function mutation with altered features that are predicted to increase neuronal excitability and seizure susceptibility. Phenytoin is an effective inhibitor of the mutant channel and may be of use in treating patients with gain-of-function mutations of SCN8A."
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,27267376,"Epilepsy-associated mutations in the voltage-gated sodium channel Nav1.6, but not Nav1.1, upregulate resurgent currents; cannabidiol preferentially targets these currents."
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,27210545,"we report an infant and his father with early onset focal epileptic seizures but without cognitive or neurological impairment in whom next generation sequence analysis identified a heterozygous mutation (c.5630A > G, p. (Asn1877Ser)) in the SCN8A gene"
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,26994141,"Either the FGF14(V160A) or the FGF14(K74A/I76A) mutation was sufficient to abolish the FGF14-dependent regulation of peak transient Na(+) currents and the voltage-dependent activation and steady-state inactivation of Nav1.6; but only V160A with a concomitant alanine mutation at Tyr-158 could impede FGF14-dependent modulation of the channel fast inactivation."
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,26974309,"the calpain-dependent cleavage of Nav1.6 channels expressed in human embryonic kidney (HEK) 293 cells caused the upregulation of I(NaP)"
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,26677014,"Our study establishes SCN8A as a novel gene in which a recurrent mutation causes BFIS/ICCA, expanding the clinical-genetic spectrum of combined epileptic and dyskinetic syndromes."
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,26182346,"Human Nav1.6 channels generate larger resurgent currents than human Nav1.1 channels, but the SCN4B-derived Navbeta4 peptide does not protect either isoform from use-dependent reduction."
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,25818041,"Epileptic encephalopathy related to mutations in the SCN8A genes."
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,25804238,"Expression profiling of SCN8A and NDUFC2 genes in colorectal carcinoma is reported. There was no NDUFC2 differential expression in colorectal carcinoma."
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,25785782,"The results of this study suggested that SCN8A mutation cause early onset epilepsy and intellectual disability."
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,25725044,"These data strengthen previous findings linking gain-of-function mutations of SCN8A with EIEE and demonstrate the importance of functional testing in establishing the pathogenicity of de novo mutations."
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,25659151,"identified the PI3K/Akt pathway, the cell-cycle regulator Wee1 kinase, and protein kinase C (PKC) as prospective regulatory nodes of neuronal excitability through modulation of the FGF14:Nav1.6 complex."
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,25568300,"SCN8A encephalopathy presents in infancy with multiple seizure types."
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,24888894,"SCN8A mutations can cause variable phenotypes, most of which can be diagnosed as unclassified early onset epileptic encephalopathies, and rarely as malignant migrating partial seizures in infancy."
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,24874546,"Data support the contribution of gain-of-function mutations of Nav1.6 (de novo variant p.Thr767Ile) that increase excitatory pyramidal neuron excitability"
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,23640885,"inhibition of GSK3 reduces the assembly of the FGF14.Nav channel complex, modifies FGF14-dependent regulation of Na(+) currents, and induces dissociation and subcellular redistribution of the native FGF14.Nav channel complex in hippocampal neurons."
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,22365152,"Discovered a de novo heterozygous missense mutation (c.5302A>G [p.Asn1768Asp]) in the voltage-gated sodium-channel gene SCN8A in the proband."
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,21630263,"We conclude that Na(V) 1.6 is upregulated in CaC and could serve as a novel molecular marker for the metastatic behavior of this carcinoma."
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,21562192,"The beta-subunits differentially regulate the expression and gating of Nav1.8 and Nav1.6 in dorsal root ganglion neurons."
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,21156207,"Genetic variants of the SCN8A voltage-gated ion channel influence not only the phenotype of mice carrying the SCN1A mutation but also the seizure frequency."
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,20632842,"Our findings suggest that the SCN8A gene may be involved in the susceptibility to suicidal behavior among psychiatric disorder patients in the Han Chinese population."
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,20632842,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,20600647,"Results show no significant difference in the size or immunofluorescence staining intensity of Na(v)1.6 nodal accumulations located at either typical or atypical nodal sites within axons in normal samples when compared to painful samples."
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,20483028,"An important mechanism of electroacupuncture therapy is its regulation of Nav1.6 and Nav1.1 expression after ischemia."
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,20421839,"Significant up-regulation of mRNA and protein for Nav1.6 is observed in rat hippocampal neurons following fluid percussion traumatic brain injury in an animal trial."
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,20379614,"Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,20204400,"Using the whole-cell configuration of the patch-clamp technique, we investigated the Na(v)1.6 transient and persistent currents in HEK-293 cells."
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,19352218,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,19136557,"a variant of NaV1.6 participates in the control of podosome and invadopodia formation and suggest that intracellular sodium release mediated by NaV1.6 may regulate cellular invasion of macrophages and melanoma cells."
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,18812204,"he results of this study indicate that SCN8A may be a potential susceptibility gene for bipolar disorder in the Han Chinese population."
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,18812204,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,18718804,"The data of this study suggested that mutations of SCN8A are unlikely to be a major cause of autosomal dominant essential tremor in Caucasian patients."
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,18718804,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,17881658,"results demonstrate that genetic interactions can alter seizure severity and support the hypothesis that genetic modifiers contribute to the clinical variability observed in severe myoclonic epilepsy of infancy"
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,17805013,"Different mechanisms underlie axonal degeneration in acute and chronic multiple sclerosis, with axonal injury at sites of coexpression of Nav1.6 and sodium-calcium exchanger in acute lesions but independent of coexpression in chronic lesions."
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,16775201,"Mmbrane-binding domain of ankyrin-G is critical for reducing the persistent sodium current of Nav1.6."
https://pharos.nih.gov/idg/targets/Q9UQD0,Q9UQD0,16702217,"Beta-scorpion toxin enhance channel activation, which could make it a model drug to replace deep brain stimulation of the subthalamic nucleus in patients with Parkinson disease."
https://pharos.nih.gov/idg/targets/P35499,P35499,28330959,"Cohort of 30 patients carrying the c.3466G>A p.A1156T mutation in the SCN4A gene showed a consistent phenotype of predominant myalgia, muscle stiffness, and exercise cramps without signs of clinical myotonia, paramyotonia, or periodic paralyses; modest gain in the function of p.A1156T channel in whole-cell patch clamp studies may explain the absence of clinical myotonia"
https://pharos.nih.gov/idg/targets/P35499,P35499,28012096,"A rare variant p.Pro1629Leu in SCN4A identified in a patient with a skeletal muscle deficit and intermittent dysphagia."
https://pharos.nih.gov/idg/targets/P35499,P35499,27714768,"We identified a novel Nav 1.4 mutation I692M in 14 families out of the 104 genetically identified Hyperkalemic periodic paralysis (HyperPP) families in the Neuromuscular Centre Ulm and is therefore as frequent as I693T (13 families out of 14 HyperPP families) in Germany. Surprisingly, in 13 families, a known polymorphism S906T was also present"
https://pharos.nih.gov/idg/targets/P35499,P35499,27415035,"Combining our results with the literature on Chinese populations indicates that 21 mutations in CLCN1 have been associated with myotonia congenital, while 7 mutations in SCN4A have been associated with paramyotonia congenita, 2 mutations in SCN4A have been associated with sodium channel myotonias."
https://pharos.nih.gov/idg/targets/P35499,P35499,27060299,"The c.4427 T>C (p.Met1476Thr) mutation of the SCN4A gene contribute to the paramyotonia congenita."
https://pharos.nih.gov/idg/targets/P35499,P35499,26700687,"Recessive loss-of-function SCN4A mutations were identified in congenital myopathy patients."
https://pharos.nih.gov/idg/targets/P35499,P35499,26494408,"Computer simulations of the effects of the I693T mutation were introduced in the muscle fiber model by both hyperpolarizing shifts in the Nav1.4 channel activation and a faster recovery from slow channel inactivation"
https://pharos.nih.gov/idg/targets/P35499,P35499,26427606,"association of the genetic variability of SCN4A with the development of essential tremor"
https://pharos.nih.gov/idg/targets/P35499,P35499,26252573,"CACNA1S and SCN4A mutations are relatively rare in patients with hypokalemic periodic paralysis"
https://pharos.nih.gov/idg/targets/P35499,P35499,26036855,"These data suggest a possible involvement of SCN4A variants in the pathophysiological mechanism underlying the development of a spontaneous or drug-induced type 1 electrocardiographic pattern and the occurrence of malignant arrhythmias in some patients with Brugada syndrome."
https://pharos.nih.gov/idg/targets/P35499,P35499,25839108,"As the result, heterozygous mutations c.2024G>A (R675Q) and c.1333G>A (V445M) of gene SCN4A were identified in the hypokalemic periodic paralysis patient and the paramyotonia congenita family respectively."
https://pharos.nih.gov/idg/targets/P35499,P35499,25755818,"A Val1589Met mutation at exon 24 of the SCN4A gene appears in affected subjects with a mild form of paramyotonia, while healthy members had a point mutation at position 1513 at exon 24 of the SCN4A gene"
https://pharos.nih.gov/idg/targets/P35499,P35499,25735906,"Mutation analysis in the patient and in child's mother revealed a heterozygous p.N1180I mutation in exon 19 of SCN4A gene. In newborns with stiffness, peripheral contractures and myotonia, the sequence analysis of SCN4A gene should be performed."
https://pharos.nih.gov/idg/targets/P35499,P35499,25724373,"The patient with scn4a mutation exhibited various symptoms that evolved with age, including apneic episodes, tonic muscular contractions during sleep, fluctuating severe episodic myotonia, and finally episodic paralyses."
https://pharos.nih.gov/idg/targets/P35499,P35499,25707578,"A homozygous mutation in Nav 1.4 at position 1457 (Arg1457His) was identified in congenital myasthenic syndrome."
https://pharos.nih.gov/idg/targets/P35499,P35499,25660391,"Electrophysiological studies of the SCN4A P72L variant showed a hyperpolarizing shift (-5 mV) of the voltage dependence of activation that may increase cell excitability"
https://pharos.nih.gov/idg/targets/P35499,P35499,25450184,"The data indicate that sialic acids attached to both N- and O-glycans residing within the Nav1.4 D1S5-S6 linker modulate channel gating through electrostatic mechanisms"
https://pharos.nih.gov/idg/targets/P35499,P35499,25348630,"report the discovery of a novel SCN4A mutation (c.1762A>G; p.I588V) in a patient with myotonia and periodic paralysis, located within the S1 segment of the second domain of the Nav1.4 channel"
https://pharos.nih.gov/idg/targets/P35499,P35499,25311598,"Patients with life-threatening laryngospasm were found to be heterozygous for the same SCN4A mutation."
https://pharos.nih.gov/idg/targets/P35499,P35499,24943082,"Its M1592V mutation of SCN4A shares a much greater clinical diversity ranging from congenital paramyotonia to periodic paralysis with a longer duration."
https://pharos.nih.gov/idg/targets/P35499,P35499,24682880,"SCN4A was functionally affected by R675Q mutation, a possible reason for causing normokalemic periodic paralysis."
https://pharos.nih.gov/idg/targets/P35499,P35499,24607901,"The effect of two single mutations of a critical tyrosine residue in the filter of NaV1.4 on tetrodotoxin binding observed experimentally is reproduced using computational mutagenesis."
https://pharos.nih.gov/idg/targets/P35499,P35499,24549961,"This work reveals a novel mechanism of disrupted S4 translocation for hypokalaemic periodic paralysis mutations at arginine residues located below the gating pore constriction of the voltage sensor module."
https://pharos.nih.gov/idg/targets/P35499,P35499,24324661,"The study demonstrates that the hNaV1.4F1705I mutation, which is linked to cold aggravated myotonia, alters the voltage dependence of inactivation and the temperature sensitivity of current kinetics."
https://pharos.nih.gov/idg/targets/P35499,P35499,23771340,"Non-dystrophic myotonias are rare diseases caused by mutations in skeletal muscle SCN4A."
https://pharos.nih.gov/idg/targets/P35499,P35499,23420899,"genetic study showed missense mutation (R1448C) in the voltage-gated sodium channel, type IV, alpha subunit"
https://pharos.nih.gov/idg/targets/P35499,P35499,23417379,"Non-dystrophic myotonias are characterised by muscle stiffness during voluntary movement owing to delayed skeletal muscle relaxation caused by mutation in the SCN4A skeletal muscle channel genes."
https://pharos.nih.gov/idg/targets/P35499,P35499,23381896,"Analyses of SCN4A, a key player in myotonia, have revealed parallels between its slow-inactivation and myotonic warm-up, which suggest that SCN4A is critical not only in producing the myotonic reaction, but also in mediating the warm-up."
https://pharos.nih.gov/idg/targets/P35499,P35499,22914841,"Nav1.4 N440K mutation causes a gain of function consistent with skeletal muscle hyperexcitability as observed in individuals with the mutation."
https://pharos.nih.gov/idg/targets/P35499,P35499,22653516,"We found significant ocular involvement in a family with a mutation in SCN4A."
https://pharos.nih.gov/idg/targets/P35499,P35499,22617007,"The patient presented a marked warm-up phenomenon of myotonia but the repeated short exercise test suggested mutations of the sodium channel."
https://pharos.nih.gov/idg/targets/P35499,P35499,22250216,"Cooling can augment the disruption of the voltage dependence of fast inactivation by mutant M1476I/Nav1.4 channels"
https://pharos.nih.gov/idg/targets/P35499,P35499,21841462,"A minority of sporadic periodic paralysis patients studied have de novo CACNA1S or SCN4A mutations and may have a variant of familial periodic paralysis."
https://pharos.nih.gov/idg/targets/P35499,P35499,21665479,"This study demonistrated that mutation of Met1592Val in the SCN4A gene is associated with aggressive development of paralysis periodica paramyotonia characterized by severe vacuolar myopathy."
https://pharos.nih.gov/idg/targets/P35499,P35499,21664816,"L1436P mutation in the SCN4A gene causes a sodium channel myotonia with an atypical clinical presentation, characterized by late onset painful cold-aggravated myotonia"
https://pharos.nih.gov/idg/targets/P35499,P35499,21606664,"The skeletal muscle alpha-subunit NaV1.4 was transiently expressed in wild-type Chinese hamster ovary (CHO) cells"
https://pharos.nih.gov/idg/targets/P35499,P35499,21521764,"Substitutions at position 799 of the Nav1.4 channel favor the channel open state with sustained activity leading to hyperexcitability of laryngeal muscles that could be lethal during infancy."
https://pharos.nih.gov/idg/targets/P35499,P35499,21317558,"ranolazine interacts with the open state and stabilizes the inactivated state(s) of Na(v)1.4 channels, causes voltage- and use-dependent block of I(Na) and suppresses persistent I(Na)"
https://pharos.nih.gov/idg/targets/P35499,P35499,21099342,"Anthopleurin elicited opposing effects on the gating mode, kinetics and charge immobilized during open- versus closed-state fast inactivation of Nav1.4 channels."
https://pharos.nih.gov/idg/targets/P35499,P35499,21043388,"study detected the SCN4A R672H mutation in one hypokalemic periodic paralysis Turkish family"
https://pharos.nih.gov/idg/targets/P35499,P35499,20713951,"Severe neonatal episodic laryngospasm is a new phenotype caused by a sodium channelopathy, which can be alleviated by channel blockers."
https://pharos.nih.gov/idg/targets/P35499,P35499,20038812,"study showed that a paroxysmal extreme pain disorder mutation in the Nav1.7 channel, a paramyotonia congenita mutation in the Nav1.4 channel & a long-QT3/SIDS mutation in the NAV1.5 channel all increased the amplitude of resurgent sodium currents"
https://pharos.nih.gov/idg/targets/P35499,P35499,19882638,"This study describes the first cases of homozygosity for two missense mutations in the SCN4A gene which increases severity of muscle channelopathies."
https://pharos.nih.gov/idg/targets/P35499,P35499,19881885,"electrostatic network interactions between S2 and other transmembrane segments within Na(v)1.4D4 are similar to but not identical to those proposed for K+ channels"
https://pharos.nih.gov/idg/targets/P35499,P35499,19840739,"confirmed missense mutation in SCN4A in myotonia congenita"
https://pharos.nih.gov/idg/targets/P35499,P35499,19773279,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35499,P35499,19347921,"This study has identified a new mutation of PAM with a severe phenotype and emphasizes the importance of the C-terminus for fast inactivation of the sodium channel(nav1.4, Q1633E)."
https://pharos.nih.gov/idg/targets/P35499,P35499,19290024,"Myoblastic cells from patients with myopathy caused by mutation SCN4A Metl592Val had a weaker ability of developing into the myotubules."
https://pharos.nih.gov/idg/targets/P35499,P35499,19211598,"The clinical guidelines proposed may help clinicians working in outpatient clinics to perform a focused genetic analysis of either CLCN1 or SCN4A."
https://pharos.nih.gov/idg/targets/P35499,P35499,19118277,"All SCN4A mutations affected arginine residues, consistent with the gating pore cation leak hypothesis of hypokalemic periodic paralysis. Arginine mutations in S4 segments underlie 90% of hypokalemic periodic paralysis cases."
https://pharos.nih.gov/idg/targets/P35499,P35499,19077043,"These observations of one family confirmed that tubular aggregates were associated with T704M mutations of SCN4A in paralysis periodica paramyotonica."
https://pharos.nih.gov/idg/targets/P35499,P35499,19015483,"A novel dominant mutation of the Nav1.4 alpha-subunit domain I leading to sodium channel myotonia."
https://pharos.nih.gov/idg/targets/P35499,P35499,18726720,"Results decribe the Thr704Met point mutation in the SCN4A gene in hyperkalemic periodic paralysis."
https://pharos.nih.gov/idg/targets/P35499,P35499,18690054,"study investigated effects of paramyotonia congenita mutations F1473S and F1705I on gating of skeletal muscle Na+ channels; results suggest that the DIV S4-S5 linker mutation F1473S promotes the hyperpolarized position of DIVS4 to accelerate recovery"
https://pharos.nih.gov/idg/targets/P35499,P35499,18337730,"CLCN1 and SCN4A mutation occurrence is associated with non-dystrophic myotonia."
https://pharos.nih.gov/idg/targets/P35499,P35499,18337730,"Observational study of genetic testing. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35499,P35499,18281721,"HyperPP is caused by mutations in the SCN4A gene that encodes the subunit of the NavCh Nav1.4 in skeletal muscles."
https://pharos.nih.gov/idg/targets/P35499,P35499,18270170,"The mechanism of calmodium modulation of Nav1.4 expression an function were studied."
https://pharos.nih.gov/idg/targets/P35499,P35499,18166706,"This study identifies two new mutations(R1448L and L1436P) confirms SCN4A as a common cause of paramyotonia congenita in the UK."
https://pharos.nih.gov/idg/targets/P35499,P35499,18079277,"State- and use-dependent block of muscle Nav1.4 voltage-gated Na+ channel isoforms by ranolazine is reported."
https://pharos.nih.gov/idg/targets/P35499,P35499,18046642,"In addition to Val-781-Ile and Met1592Val, the mutation g2101a (Arg675Gln) may be the novel mutation of SCN4A genes in Chinese patients with normoKPP."
https://pharos.nih.gov/idg/targets/P35499,P35499,17998485,"A large cohort of French-Canadians with a founder SCN4A mutation causing painful cold-induced myotonia underlines the phenotypic heterogeneity of SCN4A mutations with variants in other genes such as CLCN1 that are likely to modulate clinical expression."
https://pharos.nih.gov/idg/targets/P35499,P35499,17898326,"Consistent with other NaV1.4 mutations associated with a paralytic phenotype, the P1158S mutation disrupts slow inactivation. The unique temperature sensitivity of the channel defect may contribute to the unusual clinical phenotype."
https://pharos.nih.gov/idg/targets/P35499,P35499,17823953,"These results indicate that, in these paramyotonia congenita patients, mutant and wild-type sodium channels respond equally to cold exposure."
https://pharos.nih.gov/idg/targets/P35499,P35499,17804458,"HyperPP was suspected by means of clinical features and provocative testing, it was sequential genetic analysis that corroborated the diagnosis and identified a de novo mutation in the SCN4A gene."
https://pharos.nih.gov/idg/targets/P35499,P35499,17334961,"Warm-up phenomenon in myotonia associated with the V445M sodium channel mutation."
https://pharos.nih.gov/idg/targets/P35499,P35499,17212350,"present study has revealed a heterozygous A1481D (c.4442 C>A) missense mutation in the SCN4A gene, which was identified in family members affected with cold-aggravated myotonia in a large German kindred"
https://pharos.nih.gov/idg/targets/P35499,P35499,17151947,"Deactivation gating relies on charged ammino-acids in DIIIS4 domain."
https://pharos.nih.gov/idg/targets/P35499,P35499,16890191,"We identified a novel hypokallemic periodic paralysis type 2 mutation that neutralizes an arginine residue in DIII-S4 (R1132Q), and studied its functional consequences in HEK cells transfected with the human SCN4A cDNA."
https://pharos.nih.gov/idg/targets/P35499,P35499,16870577,"A missense mutation is responsible for the hypokalemic periodic paralysis in a Chinese family."
https://pharos.nih.gov/idg/targets/P35499,P35499,16506889,"Method in which voltage dependence of voltage-gated ion channel blockers can be compared using a protocol in which voltage error is compensated for in real time."
https://pharos.nih.gov/idg/targets/P35499,P35499,16392038,"Fast inactivation and deactivation gating were compared between wild-type human voltage-gated skeletal muscle sodium channel (hNaV1.4) and potassium-aggravated myotonia (PAM) mutations G1306A, G1306E, and G1306V."
https://pharos.nih.gov/idg/targets/P35499,P35499,15596759,"3 new mutations were found in codon 675:  an AA substitution of a highly conserved Arg to either a Gly, a Gln or a Trp. Hypokalemic periodic paralysis is caused by mutations affecting nearby codons as well as the change of an Arg into another AA."
https://pharos.nih.gov/idg/targets/P35499,P35499,15482957,"A novel SCN4A Arg672Cys mutation and a known CACNL1A3 Arg528His mutation were identified in in Korean hypokalemic periodic paralysis patients"
https://pharos.nih.gov/idg/targets/P35499,P35499,15459238,"fast inactivation of the Na(+) channel involves both S4-S5 loops in D3 and D4 in a cooperative manner and D3/S4-S5 also plays an important role in activation and deactivation"
https://pharos.nih.gov/idg/targets/P35499,P35499,15318338,"Cold exacerbation in two paramyotonia congenita mutant NaV1.4 channels R1448C and T1313M arises from a combination of biophysical defects that increase hyperexcitability at low temperatures."
https://pharos.nih.gov/idg/targets/P35499,P35499,15072700,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35499,P35499,14527681,"charged residues in the DIII-DIV linker may interact with structures that control slow inactivation in the voltage-gated sodium channel (hNa(V)1.4) (nav1.4)"
https://pharos.nih.gov/idg/targets/P35499,P35499,12766226,"V1442E mutation in SCN4A defines a novel disease mechanism and a novel phenotype with myasthenic features."
https://pharos.nih.gov/idg/targets/P35499,P35499,12210802,"identified the Met1592Val mutation of SCN4A in an affected descendent of the original normokalemic periodic paralysis (normoKPP) family"
https://pharos.nih.gov/idg/targets/P35498,P35498,28794249,"study presents a phenotype-genotype correlation for SCN1A; described a distinct SCN1A phenotype, early infantile SCN1A encephalopathy, which is readily distinguishable from the Dravet syndrome and genetic epilepsy with febrile seizures plus"
https://pharos.nih.gov/idg/targets/P35498,P35498,28686619,"Rather than a single common gene/variant modifying clinical outcome in SCN1A-related epilepsies, our results point to the cumulative effect of rare variants with little to no measurable phenotypic effect (i.e., typical genetic background) unless present in combination with a disease-causing truncation mutation in SCN1A."
https://pharos.nih.gov/idg/targets/P35498,P35498,28544625,"In this study, we performed exome sequencing in six patients with SCN1A-negative Dravet syndrome to identify other genes related to this disorder..the data in this study identify GABRB3 as a candidate gene for Dravet syndrome"
https://pharos.nih.gov/idg/targets/P35498,P35498,28525652,"The frequency of pathogenic variants was 4.17% in the patients with refractory epilepsy and Dravet syndrome and 11.1% in DS patients.  L1775P missense mutation was predicted to be damaging with a score of 100% by the PolyPhen-2 program."
https://pharos.nih.gov/idg/targets/P35498,P35498,28518218,"Pathogenic, likely pathogenic, and benign variants in SCNs were identified using databases of sodium channel variants. Benign variants were also identified from population-based databases. Eight algorithms commonly used to predict pathogenicity were compared. In addition, logistic regression was used to determine if a combination of algorithms could better predict pathogenicity."
https://pharos.nih.gov/idg/targets/P35498,P35498,28373025,"This study demonstrated that early-life prolonged FSs have a profound long-term impact on neuronal function and adult seizure phenotypes in a mouse model of human SCN1A dysfunction."
https://pharos.nih.gov/idg/targets/P35498,P35498,28262406,"A novel SCN1A mutation was found in an 8-year-old boy with GEFS+.  The father has the same mutation, but he only had childhood simple febrile seizures."
https://pharos.nih.gov/idg/targets/P35498,P35498,28202706,"The association study indicated that age at first seizure and frameshift mutations of SCN1A were associated with Dravet syndrome."
https://pharos.nih.gov/idg/targets/P35498,P35498,28084635,"this study showed that SCN1A testing be considered in all individuals with febrile seizures or Dravet syndrome , as well as in familial cases consistent with febrile seizures."
https://pharos.nih.gov/idg/targets/P35498,P35498,28012175,"This study found significant differences in the distribution of truncating and missense variants across the SCN1A sequence among healthy individuals, patients with Dravet syndrome."
https://pharos.nih.gov/idg/targets/P35498,P35498,27777328,"Study found in patients with focal seizures a seemingly uneven distribution of mutations within the SCN1A gene. Study identified valproic acid, stiripentol, and clobazam to be 3 medications that have the best effect on management of focal seizures due to an SCN1A mutation similar to what is seen in most cases of Dravet Syndrome."
https://pharos.nih.gov/idg/targets/P35498,P35498,27498208,"This study demonstrated that a significant higher frequency of the AG genotype (p=0.001) and G allele (p=0.006) of SCN1A polymorphism in epileptic patients than in controls."
https://pharos.nih.gov/idg/targets/P35498,P35498,27473590,"genetic variants in 3'UTR of SCN1A"
https://pharos.nih.gov/idg/targets/P35498,P35498,27458797,"Dravet syndrome-derived inhibitory neurons showed deficits in sodium currents and action potential firing, which were rescued by a Nav1.1 transgene, whereas Dravet excitatory neurons were normal."
https://pharos.nih.gov/idg/targets/P35498,P35498,27316242,"SCN1A mutations may alter axonal function, causing motor neuropathy/neuronopathy. This may contribute to gait disturbance and orthopedic misalignment, which is characteristic of patients with Dravet syndrome."
https://pharos.nih.gov/idg/targets/P35498,P35498,27264139,"Dravet syndrome is associated with mutations in the sodium channel alpha1 subunit gene (SCN1A) in 70-80% of individuals."
https://pharos.nih.gov/idg/targets/P35498,P35498,27245092,"The results further substantiate the contribution of SCN1A in response and therapy optimization with PHT monotherapy."
https://pharos.nih.gov/idg/targets/P35498,P35498,27113213,"Study reported the range of rare copy number variants found in SCN1A gene in a series of Welsh patients with childhood-onset epilepsy and intellectual disability and identified clearly or likely pathogenic CNVs in 8.8 % of the patients including 5 rare de novo deletions."
https://pharos.nih.gov/idg/targets/P35498,P35498,27066534,"The findings of this study in scn1a mutant zebrafish suggest that glucose and mitochondrial hypometabolism contribute to the pathophysiology of DS."
https://pharos.nih.gov/idg/targets/P35498,P35498,27045673,"No causative variants were identified in any of non-DS epileptic patients in our cohort, suggesting a minor, but not irrelevant role for SCN1A in patients with other types of childhood epilepsy."
https://pharos.nih.gov/idg/targets/P35498,P35498,26990884,"Evaluation of Presumably Disease Causing SCN1A Variants in a Cohort of Common Epilepsy Syndromes."
https://pharos.nih.gov/idg/targets/P35498,P35498,26969601,"A heterozygous mutation h1u-1962 T > G was identified in a patient with partial epilepsy and febrile seizures, which was aggravated by oxcarbazepine."
https://pharos.nih.gov/idg/targets/P35498,P35498,26841829,"Our findings suggest that SCN1A mutation leads to changes in the dopamine system that may contribute to the behavioral abnormalities in DS."
https://pharos.nih.gov/idg/targets/P35498,P35498,26763045,"Similar to the known FHM3 mutations, this novel mutation predicts hyperexcitability of GABAergic inhibitory neurons."
https://pharos.nih.gov/idg/targets/P35498,P35498,26747084,"The presence of SCN1A mutations and absence of mutations in ATP1A2 or CACNA1A suggest that the Polish patients represent FHM type 3."
https://pharos.nih.gov/idg/targets/P35498,P35498,26731440,"Mutations in SCN1A, the gene that encodes the alpha subunit of voltage-gated sodium channel Nav1.1, can cause epilepsies."
https://pharos.nih.gov/idg/targets/P35498,P35498,26716362,"Among these transmissions were two likely disease-causing mutations: an SCN1A mutation transmitted to an SUDC proband and her sibling with Dravet syndrome, as well as an SLC6A1 mutation in a proband with epileptic encephalopathy."
https://pharos.nih.gov/idg/targets/P35498,P35498,26637798,"This study provide the evidence SCN1A mutation releate to Autism Spectrum Disorder."
https://pharos.nih.gov/idg/targets/P35498,P35498,26614543,"Molecular genetic testing detected a de novo SCN1A gene deletion in heterozygous form, and revealed SCN1A gene associated monogenic epileptic syndrome being in the genetic background of therapy-resistant seizures."
https://pharos.nih.gov/idg/targets/P35498,P35498,26555147,"The SCN1A IVS5-91G>A SNP is associated with susceptibility to epilepsy. SNPs in EPHX1 gene are influencing CBZ metabolism and disposition"
https://pharos.nih.gov/idg/targets/P35498,P35498,26311622,"Mutations in SCN1A and SCN2A are a predisposing factor of acute encephalopathy with biphasic seizures and late reduced diffusion"
https://pharos.nih.gov/idg/targets/P35498,P35498,26252084,"The parental origins of 22 mutations of SCN1A were associated with Dravet syndrome."
https://pharos.nih.gov/idg/targets/P35498,P35498,26183863,"Retrospective study to survey the efficacy of antiepileptic drugs in Dravet syndrome with different SCN1A genotypes"
https://pharos.nih.gov/idg/targets/P35498,P35498,26182346,"Human Nav1.6 channels generate larger resurgent currents than human Nav1.1 channels, but the SCN4B-derived Navbeta4 peptide does not protect either isoform from use-dependent reduction."
https://pharos.nih.gov/idg/targets/P35498,P35498,25885068,"We describe two sibs with febrile and afebrile seizures (generalized or focal with secondary generalization) affected with a mild form of Dravet syndrome, and sharing the same mutation in SCN1A, not present in their parents"
https://pharos.nih.gov/idg/targets/P35498,P35498,25874779,"Frequency of mutations in SCN1A in Dravet syndrome and GEFS+ in Polish populations are similar to other countries"
https://pharos.nih.gov/idg/targets/P35498,P35498,25823783,"This study revealed that three polymorphisms, SCN1A IVS5-91G>A, ABCC2 c.1249 G>A and UGT2B7 c.802T>C, are associated with OXC maintenance dose and lnCDR in Han Chinese epilepsy patients"
https://pharos.nih.gov/idg/targets/P35498,P35498,25818041,"Epileptic encephalopathy related to mutations in the SCN1A genes."
https://pharos.nih.gov/idg/targets/P35498,P35498,25795284,"We report the association of two novel homozygous missense mutations of the SCN1A gene in four children with infantile epilepsies from two consanguineous pedigrees"
https://pharos.nih.gov/idg/targets/P35498,P35498,25778844,"An incidence of 1:22,000, of SCN1A-related Dravet syndrome was found in a population study in Denmark."
https://pharos.nih.gov/idg/targets/P35498,P35498,25766678,"The results of this study show that sleep disorder in DS mice arises from loss of NaV1.1 channels in forebrain GABAergic interneurons"
https://pharos.nih.gov/idg/targets/P35498,P35498,25725421,"This study revealed Scn1a-deficient DG granule cells exhibited progressively altered dendritic profile."
https://pharos.nih.gov/idg/targets/P35498,P35498,25668517,"RORA rs12912233 alone might be a possible risk variant for epilepsy in Malaysian Chinese, but that, together with RORA rs880626 and SCN1A rs3812718, this polymorphism may have a synergistic effect in the epilepsy risk in Malaysians."
https://pharos.nih.gov/idg/targets/P35498,P35498,25590135,"The c.2946 + 1G> T SCN1A mutation leads to a total skipping of exon 15 of the gene resulting in cryptogenic myoclonic epilepsy."
https://pharos.nih.gov/idg/targets/P35498,P35498,25576396,"Results show that NaV1.1 (SCN1A) folding defective mutants could be common and that mutations inducing rescuable folding defects are spread in all the domains of the channel"
https://pharos.nih.gov/idg/targets/P35498,P35498,25569746,"We report a three-generation, clinically heterogeneous family in which we identify a novel inherited splicing mutation of the SCN1A gene"
https://pharos.nih.gov/idg/targets/P35498,P35498,25338670,"There have been association between the common splice-site IVS5-91 G>A polymorphism in the SCN1A gene and responsiveness to the sodium channel blockers carbamazepine and phenytoin."
https://pharos.nih.gov/idg/targets/P35498,P35498,25281316,"This study show Increasing severity of loss-of-function mutations of NaV1.1 channels causes progressively more severe epilepsy syndromes."
https://pharos.nih.gov/idg/targets/P35498,P35498,25268096,"Results suggested that genetic variants of the SCN1A gene were associated with IS and ACTH responsiveness."
https://pharos.nih.gov/idg/targets/P35498,P35498,25155934,"This study suggested that SCN1A and ABCC2 polymorphisms may be associated with the response to CBZ/OXC in the Chinese Han population"
https://pharos.nih.gov/idg/targets/P35498,P35498,24990319,"a huge difference in electrophysiological function between SCN1A and SCN3A mutations in the pore region; this might explain the more common SCN1A mutations detected in patients with epilepsy and the more severe phenotypes associated with these mutations"
https://pharos.nih.gov/idg/targets/P35498,P35498,24953032,"Combining the TALEN and iPSC methods, we developed two iPS cell lines by generating the point mutation A5768G in the SCN1A gene, which encodes the voltage-gated sodium channel Nav1.1 alpha subunit."
https://pharos.nih.gov/idg/targets/P35498,P35498,24902755,"Malformations of cortical development and SCN1A mutations are found to co-occur."
https://pharos.nih.gov/idg/targets/P35498,P35498,24842605,"SCN1A mutation may be a clinically-useful genetic marker in order to distinguish epilepsy with febrile seizure patients from those with classic idiopathic generalised epilepsy"
https://pharos.nih.gov/idg/targets/P35498,P35498,24776920,"A novel de novo SCN1A mutation was identified in a case of infantile epileptic encephalopathy with a hyperkinetic movement disorder and hand stereotypies"
https://pharos.nih.gov/idg/targets/P35498,P35498,24707016,"We identified a novel SCN1A missense mutation p.Ile1498Met in all three tested hemiplegic migraine patients of one family."
https://pharos.nih.gov/idg/targets/P35498,P35498,24646837,"we report a novel familial hemiplegic migraine 3 kindred with an L263V SCN1A mutation in all patients"
https://pharos.nih.gov/idg/targets/P35498,P35498,24436055,"a novel role of Voltage-gated sodium channel alpha subunit type I (RACK1) in regulating SCN1A expression that participates in retinoic acid-induced neuronal differentiation of NT2 cells"
https://pharos.nih.gov/idg/targets/P35498,P35498,24434335,"The findings of this study illustrate differences in hippocampal neurons that may underlie strain- and age-dependent phenotype severity in a Dravet syndrome mouse model"
https://pharos.nih.gov/idg/targets/P35498,P35498,24372310,"SNPs in SCN1A (and KCNa1) genes are risk factors for both epilepsy and premature death."
https://pharos.nih.gov/idg/targets/P35498,P35498,24357141,"Our results corroborated the age-related changes in metabolite concentrations, and found evidence for a link between SCN1A and frontal white matter mI in healthy subjects."
https://pharos.nih.gov/idg/targets/P35498,P35498,24342961,"looking at the influence of rs10188577 on the expressed quantitative trait association patterns within the immediate vicinity of SCN1A"
https://pharos.nih.gov/idg/targets/P35498,P35498,24337656,"sodium channel polymorphisms are associated with epilepsy"
https://pharos.nih.gov/idg/targets/P35498,P35498,24328833,"Atypical, multifocal Dravet syndrome with SCN1A mutations may not be recognized because of later cognitive decline and frequent tonic seizures."
https://pharos.nih.gov/idg/targets/P35498,P35498,24315024,"Novel variations in SCN1A do not allow prediction of functional phenotypes that might explain, at least in part, the symptoms of malignant migrating partial seizures of infancy (MMPSI)."
https://pharos.nih.gov/idg/targets/P35498,P35498,24277604,"characterization of Nav1.1 wild-type, R859H, and R865G channels to physiological (37 degrees C) and febrile (40 degrees C) temperatures; results suggest that fever-induced temperatures exacerbate the gating defects of R859H or R865G mutants and may predispose mutation carriers to febrile seizures"
https://pharos.nih.gov/idg/targets/P35498,P35498,24257433,"Description of a family with genetic (generalized) epilepsy with febrile seizures plus spectrum with a novel mutation in SCN1A with an unusually wide phenotypic bandwidth within the genetic (generalized) epilepsy with febrile seizures plus spectrum"
https://pharos.nih.gov/idg/targets/P35498,P35498,24125961,"SCN1A IVS5-91G>A variant allele Chinese epilepsy patients had no significant effects on carbamazepine plasma concentrations."
https://pharos.nih.gov/idg/targets/P35498,P35498,24107939,"in macaque and human retinae, we show that NaV1.1 is concentrated in an axon initial segment (AIS)-like region of magnocellular pathway bipolar cells, a specialization not seen in transient bipolar cells of other vertebrates"
https://pharos.nih.gov/idg/targets/P35498,P35498,24101488,"Data show that NaV1.1-L1649Q is nonfunctional that are rescuable for inducing an overall gain of function because of the modifications in gating properties."
https://pharos.nih.gov/idg/targets/P35498,P35498,24076350,"present meta-analysis suggests that SCN1A IVS5N+5G>A polymorphism is a risk factor of EFS and epilepsy, especially in Caucasian"
https://pharos.nih.gov/idg/targets/P35498,P35498,24014518,"SCN1A involvement in a common epilepsy syndrome, give new direction to biological understanding of mesial temporal lobe epilepsy with hippocampal sclerosis"
https://pharos.nih.gov/idg/targets/P35498,P35498,23965409,"the time course of declining expression of the murine embryonic sodium channel Nav 1.3 and the rise in expression of the adult sodium channel Nav 1.1 with susceptibility to epileptic seizures and increased incidence of sudden death"
https://pharos.nih.gov/idg/targets/P35498,P35498,23916143,"Our study suggests that SCN1A genetic mutation is only a rare predisposing cause of hemiconvulsion-hemiplegia-epilepsy syndrome"
https://pharos.nih.gov/idg/targets/P35498,P35498,23884151,"Comprehensive information on epilepsy-associated SCN1A gene variants, their frequency, the predicted effect on the protein, the ethnicity of the affected along with the inheritance pattern and the associated epileptic phenotype.[review]"
https://pharos.nih.gov/idg/targets/P35498,P35498,23859570,"Our data from the Hong Kong and Malaysia cohorts showed no significant allele, genotype and haplotype association of polymorphisms in the SCN1A, SCN2A, and SCN3A genes with drug responsiveness in epilepsy."
https://pharos.nih.gov/idg/targets/P35498,P35498,23786015,"Single nucleotide polymorphisms in ABCB1 and SCN1A genes significantly correlate with drug resistance to antiepileptic agents in patients with epilepsy."
https://pharos.nih.gov/idg/targets/P35498,P35498,23762420,"SCN1A mutations predispose children to the Dravet syndrome with seizures following vaccination."
https://pharos.nih.gov/idg/targets/P35498,P35498,23752739,"The study validated gender-dependent association between genomic SCN1A rs3812718 polymorphism and TTR in CRC patients treated with adjuvant 5-FU-based chemotherapy."
https://pharos.nih.gov/idg/targets/P35498,P35498,23485646,"Three missense mutations and two frameshift mutations in the SCN1A gene have been found in the Taiwanese patients with Dravet syndrome."
https://pharos.nih.gov/idg/targets/P35498,P35498,23466530,"we report that SCN1AIVS5-91G>A polymorphism is associated with epilepsy susceptibility but not with drug responsiveness"
https://pharos.nih.gov/idg/targets/P35498,P35498,23398611,"Our results demonstrate that mutations of Nav1.1 may give rise to different phenotypes of epilepsy and FHM in the same family"
https://pharos.nih.gov/idg/targets/P35498,P35498,23398550,"This study demonistrated that in patients with SCN1A-positive Dravet syndrome different neuronal networks underlie the individual."
https://pharos.nih.gov/idg/targets/P35498,P35498,23291792,"Most of the cases of Dravet syndrome have the SCN1A mutation."
https://pharos.nih.gov/idg/targets/P35498,P35498,23225037,"Characterization of SCN1A gene mutations and their inheritance in patients with Dravet syndrome."
https://pharos.nih.gov/idg/targets/P35498,P35498,23195492,"Our study indicates that the prevalence of SCN1A mutation in patients with suspected myoclonic epilepsy of infancy, borderline phenotype and intractable epilepsy is 56.2%, 41.9% and 28.9% respectively"
https://pharos.nih.gov/idg/targets/P35498,P35498,23158734,"Missense mutations in SCN1A were common in generalized epilepsy with febrile seizures plus families, few with truncation mutations."
https://pharos.nih.gov/idg/targets/P35498,P35498,23093055,"SCN1A mutations and/or microchromosomal rearrangements involving SCN1A are detected in about 85 of patients [review]"
https://pharos.nih.gov/idg/targets/P35498,P35498,23086956,"certain nontruncating SCN1A mutations associated with SMEI have impaired cell surface expression and that some alleles may be amenable to pharmacological rescue of this defect."
https://pharos.nih.gov/idg/targets/P35498,P35498,23066759,"Mutations in SCN1A and other genes with rare copy number variations are not responsible for febrile infection-related epilepsy syndrome (FIRES)."
https://pharos.nih.gov/idg/targets/P35498,P35498,23057548,"SCN1A IVS5N+5 polymorphism was genotyped in 583 Malaysian and Hong Kong Chinese epilepsy patients receiving sodium valproate monotherapy. We did not demonstrate an association between antiepileptic responsiveness and this polymorphism."
https://pharos.nih.gov/idg/targets/P35498,P35498,22992729,"Identification of the cysteine residue responsible for disulfide linkage of Na+ channel alpha and beta2 subunits"
https://pharos.nih.gov/idg/targets/P35498,P35498,22949513,"Generalized epilepsies implicates susceptibility genes: CHRM3 at 1q43, VRK2 at 2p16.1, ZEB2 at 2q22.3, SCN1A at 2q24.3 and PNPO at 17q21.32."
https://pharos.nih.gov/idg/targets/P35498,P35498,22944210,"Ths results of this study suggested that genetic defects of the SCN1A gene are likely to play a role in the etiology of GEFS+ in our Malaysian patients."
https://pharos.nih.gov/idg/targets/P35498,P35498,22848613,"SCN1A and PCDH19 mutations in Chinese children with Dravet syndrome"
https://pharos.nih.gov/idg/targets/P35498,P35498,22780858,"missense and nonsense mutations in patients with Dravet syndrome, and relation to seizure frequency and gait disorders"
https://pharos.nih.gov/idg/targets/P35498,P35498,22719002,"A large cohort of patients presents with SCN1A mutation-positive Dravet syndrome, with the objective of identifying predictors of developmental outcome and to determine specific clinical and demographic features.."
https://pharos.nih.gov/idg/targets/P35498,P35498,22578703,"We conclude that in the population studied, although rs3812718 polymorphism increases the susceptibility to medial temporal lobe epilepsy, this is not by increasing the susceptibility to febrile seizures."
https://pharos.nih.gov/idg/targets/P35498,P35498,22534457,"the present results suggest that the SCN1A polymorphism has modulatory effects on brain morphology and vulnerability to age-related alterations in brain activity of cortical regions that subserve working memory."
https://pharos.nih.gov/idg/targets/P35498,P35498,22532537,"The results of this study concluded that mesial temporal sclerosis is a common finding in children with SCN1A mutations"
https://pharos.nih.gov/idg/targets/P35498,P35498,22430156,"This study concluded that bromide holds promise in patients with SCN1A-mutations suffering from Dravet syndrome."
https://pharos.nih.gov/idg/targets/P35498,P35498,22386634,"Given the knowledge that SCN1A mutations can render severe consequences in a previously normal infant with Dravet syndrome, it remains possible that febrile infection-related epilepsy syndrome (FIRES) also has a genetic basis in 10 patients with FIRES."
https://pharos.nih.gov/idg/targets/P35498,P35498,22341965,"Dravet syndrome is a childhood disorder associated with loss-of-function mutations in SCN1A that is characterized by frequent, refractory seizures and permanent cognitive impairment."
https://pharos.nih.gov/idg/targets/P35498,P35498,22309220,"SCN1A mutations are a predisposing factor for the onset of various types of acute encephalopathy."
https://pharos.nih.gov/idg/targets/P35498,P35498,22292851,"The rs3812718 single nucleotide polymorphism in the SCN1A gene is significantly associated with the retention rate of carbamazepine monotherapy in Chinese Han patients with focal epilepsy."
https://pharos.nih.gov/idg/targets/P35498,P35498,22206733,"Our findings indicate that while microdeletions are not rare in SCN1A-negative Dravet syndrome patients, they are not likely to be present simultaneously with other SCN1A mutations."
https://pharos.nih.gov/idg/targets/P35498,P35498,22188362,"the present study revealed that EPHX1, UGT2B7 and SCN1A genetic polymorphisms simultaneously modulated the CBZ maintenance doses and CDRs(concentration-dose ratios)"
https://pharos.nih.gov/idg/targets/P35498,P35498,22151702,"This is the first report of mosaic SCN1A mutations in families with probands that do not exhibit Dravet syndrome, but manifest only a milder phenotype."
https://pharos.nih.gov/idg/targets/P35498,P35498,22150645,"Data show pure haploinsufficiency for Dravet syndrome Na(V)1.1 (SCN1A) sodium channel truncating mutations."
https://pharos.nih.gov/idg/targets/P35498,P35498,22147323,"Two different mutations were found in 2 patients with severe myoclonic epilepsy of infancy. A novel mutation was identified in case 1. In case 2, a previously identifed mutation was found."
https://pharos.nih.gov/idg/targets/P35498,P35498,22071555,"SCN1A gene mutations are strongly associated to a more severe phenotype in patients with Dravet syndrome."
https://pharos.nih.gov/idg/targets/P35498,P35498,22014581,"SCN1A gene does not contribute significantly to susceptibility to autonomic seizures during fever in patients with Panayiotopoulos syndrome."
https://pharos.nih.gov/idg/targets/P35498,P35498,22011963,"Mutation analysis of the SCN1B, SCN1A and GABRG2 genes in children affected by Genetic (Generalised) Epilepsy with Febrile Seizures plus was performed"
https://pharos.nih.gov/idg/targets/P35498,P35498,22000312,"A high-sensitivity testing strategy fis demonstrated for detecting mutations of SCN1A in children with suspected Dravet syndrome."
https://pharos.nih.gov/idg/targets/P35498,P35498,21940124,"results demonstrate that Scn1a mutations result in an age-dependent alteration in oscillatory process."
https://pharos.nih.gov/idg/targets/P35498,P35498,21906962,"Two children were found to have pathological mutations in the SCN1A gene and defects in mitochondrial electron transport chain complex activity"
https://pharos.nih.gov/idg/targets/P35498,P35498,21890636,"Alternative splicing modulates inactivation of type 1 voltage-gated sodium channels by toggling an amino acid in the first S3-S4 linker."
https://pharos.nih.gov/idg/targets/P35498,P35498,21881118,"We identified a variant in each of 3 genes (RFC1, SCN1A, ANPEP) potentially implicated in susceptibility to severe neurological complications in West Nile Virus disease."
https://pharos.nih.gov/idg/targets/P35498,P35498,21868258,"SCN1A mutational analysis of Korean Dravet syndrome patients resulted in the identification of 15 novel mutations"
https://pharos.nih.gov/idg/targets/P35498,P35498,21864321,"Results suggest that the R859H mutation causes genetic epilepsy with febrile seizures-plus by a mixture of biophysical defects in Na(v) 1.1 gating."
https://pharos.nih.gov/idg/targets/P35498,P35498,21843600,"Our results expand the spectrum of SCN1A mutations and provide novel insights between the SCN1A mutations and the clinical variations of Generalized epilepsy with febrile seizures plus."
https://pharos.nih.gov/idg/targets/P35498,P35498,21762453,"SNP rs3812718 involvement in febrile seizure vulnerability"
https://pharos.nih.gov/idg/targets/P35498,P35498,21753172,"results implicate SCN1A as causative in some patients with MPSI."
https://pharos.nih.gov/idg/targets/P35498,P35498,21726526,"Nav1.1 can be regulated by CaM and by Ca++ alone; these effectors may antagonize each other."
https://pharos.nih.gov/idg/targets/P35498,P35498,21713554,"We excluded the role of the SCN1A gene in the pathogenesis of comorbidity between headache (especially migraine) and epilepsy"
https://pharos.nih.gov/idg/targets/P35498,P35498,21561445,"THESE FINDINGS RULE OUT A MAJOR ROLE OF THE"
https://pharos.nih.gov/idg/targets/P35498,P35498,21555645,"This report expands the spectrum of SCN1A (missense mutation) epileptic channelopathies to include malignant migrating partial seizures of infancy."
https://pharos.nih.gov/idg/targets/P35498,P35498,21531204,"The sequencing analyses of the SCN1A gene revealed the presence of a putative disease-associated haplotype in two patients affected with Dravet syndrome."
https://pharos.nih.gov/idg/targets/P35498,P35498,21504426,"variability in phenotype severity within a single family favours the concept that SCN1A loss of function causes a spectrum of epilepsy and cognitive phenotypes in which seizures precipitated by fever are the prominent feature in Davet syndrome [review]"
https://pharos.nih.gov/idg/targets/P35498,P35498,21504425,"De novo mutations in SCN1A account for approximately 70% of all Dravet patients, and approximately 25% of female SCN1A-negative Dravet patients have a PCDH19 mutation [Review]."
https://pharos.nih.gov/idg/targets/P35498,P35498,21426328,"3 cases of SCN1A mutation associated epilepsy who experienced sustained neurologic regression after status epilepticus in 2 and acute sepsis in 1; report adds to spectrum of neurologic deterioration and functional deficit associated with SCN1A mutation"
https://pharos.nih.gov/idg/targets/P35498,P35498,21396429,"We report on two patients with SCN1A mutations and severe epilepsy within the spectrum of generalized epilepsy with febrile seizures plus syndrome"
https://pharos.nih.gov/idg/targets/P35498,P35498,21377452,"We studied the developmental changes of Na(v)1.1 and Na(v)1.2 in the human hippocampus and temporal lobe"
https://pharos.nih.gov/idg/targets/P35498,P35498,21371021,"Adult patients with a history of severe epilepsy at a young age should be aware of the possibility of milder forms of Dravet syndrome and should consider analysis of the SCN1A gene."
https://pharos.nih.gov/idg/targets/P35498,P35498,21248271,"This study suggested that the nature of a SCN1A mutation may influence the epilepsy phenotype."
https://pharos.nih.gov/idg/targets/P35498,P35498,21156207,"When voltage-gated ion channel SCN1A is combined with SCN8A, seizures caused by the SCN1A allele are reduced."
https://pharos.nih.gov/idg/targets/P35498,P35498,20879882,"study of twins with de novo mutations in SCN1A causing Dravet's syndrome; on the basis of findings and literature on mosaic cases, conclude de novo mutations in SCN1A may occur at any time from the premorula stage of the embryo to adulthood"
https://pharos.nih.gov/idg/targets/P35498,P35498,20682179,"four novel allelic variants as missense substitutions included two new sequence variations (p.F412 I, p.Y1274N) and two previously reported mutations (p.R101G, p.S103G) detected in 4/34 epileptic probands but not in control groups or normal family members"
https://pharos.nih.gov/idg/targets/P35498,P35498,20675100,"The SCN1A-R1575C mutation is detected in a patient with a history of acute encephalitis with refractory, repetitive partial seizures and in the patient's healthy father."
https://pharos.nih.gov/idg/targets/P35498,P35498,20630778,"we first identified two novel de novo truncation mutations (S662X and M145fx148) in two patients whose phenotypes were quite milder compared with severe myoclonic epilepsy of infancy patients"
https://pharos.nih.gov/idg/targets/P35498,P35498,20602612,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35498,P35498,20600615,"The spectrum of SCN1A mutations extends to generalized epilepsy with febrile seizures and further confirms the contribution of sodium channel genes to the etiology of idiopathic epilepsies."
https://pharos.nih.gov/idg/targets/P35498,P35498,20522430,"Data revealed inherited mutations including four nonsense mutations, three mutations altering the splice sites, two exonic deletions of one base pair, one whole gene deletion, and nine missense mutations."
https://pharos.nih.gov/idg/targets/P35498,P35498,20519669,"SCN1A mutations are probably not associated with benign convulsions accompanied by mild gastroenteritis in previously healthy infants or young children."
https://pharos.nih.gov/idg/targets/P35498,P35498,20506560,"Data show that microdeletion limited to the SCN1A 5' promoter region with the coding sequence preserved, and indicate the critical involvement of this upstream region in the molecular pathology of Dravet syndrome."
https://pharos.nih.gov/idg/targets/P35498,P35498,20484682,"In four generations of a Bulgarian family a SCN1A haploinsufficiency is associated with an epileptic disorder with mild to severe mental retardation."
https://pharos.nih.gov/idg/targets/P35498,P35498,20477842,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35498,P35498,20452746,"the majority of Generalized epilepsy with febrile seizures patients in Indonesia were not associated with SCN1A mutations."
https://pharos.nih.gov/idg/targets/P35498,P35498,20447868,"Vaccination might trigger earlier onset of Dravet syndrome; however, vaccination should not be withheld from children with SCN1A mutations because we found no evidence that vaccinations before or after disease onset affect outcome."
https://pharos.nih.gov/idg/targets/P35498,P35498,20431604,"SCN1A mutations in 63 Chinese patients with Dravet syndrome were investigated and its inheritance, was analyzed."
https://pharos.nih.gov/idg/targets/P35498,P35498,20410126,"A missense mutation (N1417H) of the Na(v)1.1 channel confers susceptibility to febrile seizure."
https://pharos.nih.gov/idg/targets/P35498,P35498,20194124,"We propose a unified loss-of-function hypothesis for the spectrum of epilepsy syndromes caused by genetic changes in NaV1.1 channels--REVIEW"
https://pharos.nih.gov/idg/targets/P35498,P35498,20117752,"point mutation (c.3925 C>T) in exon 20 of the SCN1A gene epilepsy with febrile seizures patients"
https://pharos.nih.gov/idg/targets/P35498,P35498,20110217,"In this study the authors present four novel mutations and confirm two previously identified mutations in the SCN1A gene found in a cohort of Turkish patients with Dravet syndrome."
https://pharos.nih.gov/idg/targets/P35498,P35498,20064729,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35498,P35498,20038948,"The results of this study suggested an important role for SCN1A in human short-term memory."
https://pharos.nih.gov/idg/targets/P35498,P35498,20038948,"Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35498,P35498,20037572,"The significantly higher frequency of the SCN1A mutation in the group of patients with epilepsy compared to the control group of Caucasians (45,5 and 21,3%, respectively) implies that this polymorphism may contribute to the pathogenesis of epilepsy."
https://pharos.nih.gov/idg/targets/P35498,P35498,20037572,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35498,P35498,19949041,"No association between SCN1A and Single Nucleotide Polymorphism and febrile seizures."
https://pharos.nih.gov/idg/targets/P35498,P35498,19782004,"the significance of SCN1A mutations also in epileptic disorders with features of LGS, particularly in the myoclonic variant of the disorder"
https://pharos.nih.gov/idg/targets/P35498,P35498,19694741,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35498,P35498,19673951,"Parental SCN1A mutation mosaicism in familial Dravet syndrome."
https://pharos.nih.gov/idg/targets/P35498,P35498,19589774,"The parental origin of SCN1A mutations was established in 44 patients for whom both parents were available and SNPs were informative. The mutations were of paternal origin in 33 cases and of maternal origin in the remaining 11 cases."
https://pharos.nih.gov/idg/targets/P35498,P35498,19586930,"Missense mutations that decrease protein hydrophobicity are significantly associated with severe epilepsy phenotypes."
https://pharos.nih.gov/idg/targets/P35498,P35498,19586930,"Meta-analysis of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35498,P35498,19585586,"developed an online and freely available database containing all reported sequence variants in SCN1A"
https://pharos.nih.gov/idg/targets/P35498,P35498,19563458,"amino acids substitution in p.V1612I and p.C1756G were determined as myoclonic epilepsy-causing mutations"
https://pharos.nih.gov/idg/targets/P35498,P35498,19522081,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35498,P35498,19469841,"mutations in SCN1A are associated with a wide range of human epilepsy syndromes and rare cases of familial migraine; functional defects range from loss- to gain-of-function [review]"
https://pharos.nih.gov/idg/targets/P35498,P35498,19464834,"mutations in the SCN1A gene are differentially involved in the pathogenesis of and sequence variations of the KCNQ2 and KCNQ3 genes may contribute to the etiology of rare and common idiopathic epilepsy syndromes [review]"
https://pharos.nih.gov/idg/targets/P35498,P35498,19464195,"A novel missense mutation in the pore-forming region of the sodium channel gene SCN1A causes generalized epilepsy with febrile seizures with a variable phenotype that includes mood and anxiety disorders, as well as ataxia."
https://pharos.nih.gov/idg/targets/P35498,P35498,19402159,"loss of function caused by folding defects that can be attenuated by molecular interactions may be a common pathogenic mechanism for Na(v)1.1 epileptogenic mutants."
https://pharos.nih.gov/idg/targets/P35498,P35498,19400878,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35498,P35498,19350499,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35498,P35498,19339291,"Our findings suggest that SCN1A mutations may cause susceptibility to an idiopathic focal epilepsy phenotype, the final phenotype depending on other (genetic or nongenetic) factors."
https://pharos.nih.gov/idg/targets/P35498,P35498,19332696,"Two novel SCN1A mutations are identified that are associated with repetitive daily blindness and hemiplegic migraine."
https://pharos.nih.gov/idg/targets/P35498,P35498,19292758,"This study found patients with febrile seizures and febrile seizure with Dravet syndrome with SCN1A mutations had earlier median onset of febrile seizures compared to the population median."
https://pharos.nih.gov/idg/targets/P35498,P35498,19292758,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35498,P35498,19289736,"The A-allele of a SCN1A single nucleotide polymorphism represents a common and relevant risk factor for febrile seizures"
https://pharos.nih.gov/idg/targets/P35498,P35498,19289736,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35498,P35498,19270815,"Observational study of gene-disease association, gene-gene interaction, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35498,P35498,19236456,"Our results support that SCN1A is the responsible gene for GEFS+ in one of the two studied Tunisian families and suggest a positive association of an intronic SNP in the GABRG2 gene in both families."
https://pharos.nih.gov/idg/targets/P35498,P35498,19220312,"The results extend the clinical spectrum associated with SCN1A mutations and further strengthen the molecular evidence that familial hemiplegic migraine and epilepsy share, at least in part, similar molecular pathways."
https://pharos.nih.gov/idg/targets/P35498,P35498,19214208,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35498,P35498,19200853,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35498,P35498,19099883,"SCN1A gene mutation was associated with severe myoclonic epilepsy of infancy."
https://pharos.nih.gov/idg/targets/P35498,P35498,19070316,"The presence of an SCN1A mutation supports the diagnosis of Severe Myoclonic Epilepsy of Infancy (SMEI)."
https://pharos.nih.gov/idg/targets/P35498,P35498,19007941,"familial hemiplegic migraine 3 is a high resistant molecule when compared to FHM1 and FHM2"
https://pharos.nih.gov/idg/targets/P35498,P35498,18930999,"Results suggests the mutation spectrum of SCN1A, including whole gene deletions, favors haploinsufficiency as the main mechanism responsible for Dravet syndrome (Severe myoclonic epilepsy of infancy)."
https://pharos.nih.gov/idg/targets/P35498,P35498,18930999,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35498,P35498,18784617,"The association of antiepileptic drugs responsiveness with genetic polymorphisms was investigated and any association with mRNA expression of the neuronal sodium channels was correlated."
https://pharos.nih.gov/idg/targets/P35498,P35498,18784617,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35498,P35498,18680191,"A novel SCN1A frameshift mutation without protein truncation was observed in a case of severe myoclonic epilepsy of infancy."
https://pharos.nih.gov/idg/targets/P35498,P35498,18655196,"The 5'-untranslated exons could greatly enhance gene expression in SCN1A"
https://pharos.nih.gov/idg/targets/P35498,P35498,18632931,"Mutation of the familial hemiplegic migraine (type 3) SCN1A channel affects the gating properties of the channel, consistent with both hyperexitability and hypoexcitability."
https://pharos.nih.gov/idg/targets/P35498,P35498,18621678,"a complex spectrum of Na(V)1.1 defects can cause FHM3"
https://pharos.nih.gov/idg/targets/P35498,P35498,18566737,"Novel neuronal sodium channel voltage-gated type I alpha subunit (SCN1A) and ligand-gated gamma aminobutyric acid receptor (GABRG)2 gene mutations are found in two unrelated Chinese families with generalized epilepsy with febrile seizures plus (GEFS+)."
https://pharos.nih.gov/idg/targets/P35498,P35498,18554361,"We did not find a significant difference in the average carbamazepine doses between the genotype groups."
https://pharos.nih.gov/idg/targets/P35498,P35498,18554360,"The SCN1A mutation may modulate the excitoxicity-associated increase in NMDA-induced calcium influx, thus providing protection in the same way as the association of Kcna1 and Cacna1a was beneficial in the digenic mutant mouse."
https://pharos.nih.gov/idg/targets/P35498,P35498,18554359,"It is still unknown whether SCN1A is the major pathogenic gene in Chinese SMEI patients. We have now performed mutation analysis of the SCN1A gene in a population of Chinese SMEI patients."
https://pharos.nih.gov/idg/targets/P35498,P35498,18489610,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35498,P35498,18479393,"microchromosomal deletions involve SCN1A gene in severe myoclonic epilepsy in infancy."
https://pharos.nih.gov/idg/targets/P35498,P35498,18451712,"The identification of a second Familial hemiplegic migraine (FHM3) SCN1A mutation definitely established SCN1A as a migraine gene [review]"
https://pharos.nih.gov/idg/targets/P35498,P35498,18413471,"No large deletions at the SCN1A locus were found in any of the patients.  13 different point mutations were identified in 12 patients: 10 with SMEI, 1 with generalized epilepsy with febrile seizures plus, and 1 with cryptogenic focal epilepsy."
https://pharos.nih.gov/idg/targets/P35498,P35498,18342948,"Data show that Nav1.1 sodium channel mutations cause epilepsy."
https://pharos.nih.gov/idg/targets/P35498,P35498,18330841,"Genetic analysis showed a heterozygous missense mutation (c.5311A>T: I1771F) in the patient, which was not detected in her parents."
https://pharos.nih.gov/idg/targets/P35498,P35498,18294202,"De novo balanced translocation, t(2;5)(q24.3,q34). The breakpoint on chromosome 2q24.3 truncated the SCN1A gene and the 5q34 breakpoint was within a highly conserved genomic region."
https://pharos.nih.gov/idg/targets/P35498,P35498,18275929,"Refractory, life-threatening status epilepticus in a 3-year-old girl with SCN1A mutation."
https://pharos.nih.gov/idg/targets/P35498,P35498,18251839,"study reports an otherwise typical generalized epilepsy with febrile seizures plus(GEFS+) family with a novel SCN1A mutation and two cases of sudden unexpected death in epilepsy"
https://pharos.nih.gov/idg/targets/P35498,P35498,18175077,"Febrile Seizure is not related to the most common mutations of SCN1A in two Tunisian families."
https://pharos.nih.gov/idg/targets/P35498,P35498,18093548,"Mutation in SCN1A were found in patient with epilepsy."
https://pharos.nih.gov/idg/targets/P35498,P35498,18076640,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35498,P35498,18056581,"Sequence variants were identified in seven SHM patients: one CACNA1A mutation, five ATP1A2 mutations, and one SCN1A polymorphism. All six mutations caused functional changes in cellular assays."
https://pharos.nih.gov/idg/targets/P35498,P35498,18021921,"The novel T1174S missense mutation of SCN1A gene was detected segregating in a family with a heterozygous female child and in her heterozygous mother, who had an ataxic migraine syndrome similar to that of her own mother."
https://pharos.nih.gov/idg/targets/P35498,P35498,17928445,"Nav1.1 subunit Met1841Thr mutation is trafficking defective, thus far the first case among neuronal Na+ channels."
https://pharos.nih.gov/idg/targets/P35498,P35498,17927801,"This suggests that mutations in the SCN1A gene is not a prevalent cause of familial cases of FS and epilepsy or GEFS+ in Scandinavia."
https://pharos.nih.gov/idg/targets/P35498,P35498,17621480,"In the Dravet syndrome, Six of the 7 patients (86%) who were tested for SCN1A mutations had positive results."
https://pharos.nih.gov/idg/targets/P35498,P35498,17565594,"findings illustrate that SCN1A mutations can cause simple febrile seizures associated with temporal lobe epilepsy, which differ from the characteristic clinical spectrum of generalized epilepsy with febrile seizures plus"
https://pharos.nih.gov/idg/targets/P35498,P35498,17544618,"characterization of the 5' untranslated region of SCN1A gene."
https://pharos.nih.gov/idg/targets/P35498,P35498,17537961,"Nav1.1 plays a critical role in the spike output from parvalbumin-positive interneurons and contributes to epileptic seizures in mice."
https://pharos.nih.gov/idg/targets/P35498,P35498,17507202,"SCN1A mutations may confer susceptibility to psychiatric disorders in addition to variable epileptic seizures."
https://pharos.nih.gov/idg/targets/P35498,P35498,17436242,"SCN1A polymorphism has a dramatic effect on the proportions of neonate and adult alternative transcripts of SCN1A in adult brain tissue and, the effect of the polymorphism also appears to be modified by Nova2 expression levels."
https://pharos.nih.gov/idg/targets/P35498,P35498,17397047,"identified the novel p.L1649Q mutation (c.4946T>A) in SCN1A in a North American kindred with familial hemiplegic migraine without associated ataxia or epilepsy; findings establish role of neuronal Na(v)1.1 sodium channels in FHM"
https://pharos.nih.gov/idg/targets/P35498,P35498,17347258,"Observational study of genotype prevalence. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35498,P35498,17065438,"Understanding of mutant SCN1A dysfunction in an inherited epilepsy syndrome will enable more precise computational studies of abnormal neuronal activity in epilepsy."
https://pharos.nih.gov/idg/targets/P35498,P35498,17054685,"This wide spectrum of functional defects observed among SCN1A mutations suggests that SMEI may result from more than a single molecular or cellular mechanism, or require other factors for pathogenesis."
https://pharos.nih.gov/idg/targets/P35498,P35498,17054684,"A substanial epileptic family background is not present in our SMEI patients with SCN1A mutations."
https://pharos.nih.gov/idg/targets/P35498,P35498,17030758,"Patients with severe myoclonic epilepsy of infancy (SMEI) lacking SCN1A point mutations should be investigated for cryptic chromosomal deletions involving SCN1A"
https://pharos.nih.gov/idg/targets/P35498,P35498,17001291,"Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35498,P35498,16713920,"SCN1A mutations were identified in 11 of 14 patients with alleged vaccine encephalopathy; a diagnosis of a specific epilepsy syndrome was made in all 14 cases."
https://pharos.nih.gov/idg/targets/P35498,P35498,16541393,"Two unrelated families in which two children of unaffected parents had deleterious SCN1A mutations, and show evidence of somatic and germline mosaicism in the transmitting parents."
https://pharos.nih.gov/idg/targets/P35498,P35498,16505326,"Novel truncating mutation (2528delG) of the SCN1A gene in a boy with myoclonic epilepsy."
https://pharos.nih.gov/idg/targets/P35498,P35498,16430863,"analysis of SCN1A parental mosaicism in severe myoclonic epilepsy of infancy"
https://pharos.nih.gov/idg/targets/P35498,P35498,16380441,"Our findings define single-channel properties for WT-SCN1A, detail the functional phenotypes for two human epilepsy-associated sodium channel mutants, and clarify the mechanism for increased persistent sodium current induced by the R1648H allele."
https://pharos.nih.gov/idg/targets/P35498,P35498,16326807,"Identification of an Nav1.1 sodium channel (SCN1A) loss-of-function mutation associated with familial simple febrile seizures."
https://pharos.nih.gov/idg/targets/P35498,P35498,16210358,"SCN1A mutations associated with ICEGTC (intractable childhood epilepsy with generalized tonic-clonic seizures) result in a wide spectrum of biophysical defects, including gating impairments, shifted voltage dependence and reduced use dependence."
https://pharos.nih.gov/idg/targets/P35498,P35498,16054936,"heterozygous missense mutation (Gln1489Lys) in the neuronal voltage-gated sodium channel gene SCN1A can cause familial hemiplegic migraine"
https://pharos.nih.gov/idg/targets/P35498,P35498,15880351,"epilepsy related mutations"
https://pharos.nih.gov/idg/targets/P35498,P35498,15715999,"A base substitution 5569G-->T of voltage-gated sodium channel alpha-1 subunit gene was found in DNA derived from the affected members of this family."
https://pharos.nih.gov/idg/targets/P35498,P35498,15525788,"The D1866Y mutation in SCN1A weakens the interaction between the C-terminal domains of the alpha and beta1 subunits, demonstrating a novel molecular mechanism leading to seizure susceptibility."
https://pharos.nih.gov/idg/targets/P35498,P35498,15508916,"In janese corhort study showed variuos phenotypic manifestions of Dravet syndrom in releation of SCN1A mutation."
https://pharos.nih.gov/idg/targets/P35498,P35498,15277629,"Mutations in the pore regions may produce more severe channel dysfunction, including activation/inactivation dysfunction or abnormal voltage dependency, than those in other transmembrane regions, resulting in a more severe epilepsy phenotype."
https://pharos.nih.gov/idg/targets/P35498,P35498,15263074,"Mutations in SCN1A are associated with severe myoclonic epilepsy."
https://pharos.nih.gov/idg/targets/P35498,P35498,15249644,"a role for the hemizygous deletion of not one but two sodium channel genes (SCN1A and SCN2A) in another complicated and more severe epileptic phenotype."
https://pharos.nih.gov/idg/targets/P35498,P35498,15087100,"The clinical spectrum of SCN1A mutations ranges from febrile seizures, febrile seizures plus, over a milder type to the classical form of severe myoclonic epilepsy in infancy."
https://pharos.nih.gov/idg/targets/P35498,P35498,14738421,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35498,P35498,14738421,"In both core severe myoclonic epilepsy in infancy and severe borderline myoclonic epilepsy, various mutations of SCN1A including nonsense and missense mutations were identified"
https://pharos.nih.gov/idg/targets/P35498,P35498,14672992,"The sodium channel function of SCN1A with misesense mutations is dysfunctional in familial epilepsy."
https://pharos.nih.gov/idg/targets/P35498,P35498,14504318,"8 SCN1A mutations from severe myoclonic epilepsy of infancy and 1 from West syndrome were characterized and their effect on the structure and function of the protein are discussed."
https://pharos.nih.gov/idg/targets/P35498,P35498,13129592,"Typical Severe Myoclonic Epilepsy (SME) and Borderline SME show distinct differences in photoparoxysmal response and gender, which might be caused by some genetic mechanism(s) other than the SCN1A gene mutation."
https://pharos.nih.gov/idg/targets/P35498,P35498,12919402,"Missense mutations in the SCN1A gene are major causes of generalized epilepsy with febrile seizures plus (GEFS+)."
https://pharos.nih.gov/idg/targets/P35498,P35498,12837571,"SCN1A channels bearing myoclonic epilepsy (SMEI) nonsense and missense mutations show attenuated or barely detectable inward sodium currents, indicating that SMEI mutations lead to loss-of-function and may contribute to development of SMEI phenotypes."
https://pharos.nih.gov/idg/targets/P35498,P35498,12821740,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35498,P35498,12773292,"familial severe myoclonic epilepsy of infancy is geneticlly heterogenous for SCN1A (Nav1.1)mutation"
https://pharos.nih.gov/idg/targets/P35498,P35498,12754708,"de novo mutations in SCN1A are a major cause of isolated severe myoclonic epilepsy of infancy (SMEI or Dravet syndrome)"
https://pharos.nih.gov/idg/targets/P35498,P35498,12742596,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35498,P35498,12742596,"the SCN1A gene might not be one of the susceptibility factors for febrile convulsions"
https://pharos.nih.gov/idg/targets/P35498,P35498,12610651,"R542Q in SCN1A was observed in one autism family and had previously been identified in a patient with juvenile myoclonic epilepsy"
https://pharos.nih.gov/idg/targets/P35498,P35498,12086636,"The effects of three mutations in SCN1A have been characterized in cultured mammalian cells as a gain-of-function abnormality causing prolonged membrane depolarization, a plausible underlying biophysical mechanism responsible for inherited epilepsy."
https://pharos.nih.gov/idg/targets/P35498,P35498,12083760,"Significant correlation of the SCN1A mutations and severe myoclonic epilepsy in infancy"
https://pharos.nih.gov/idg/targets/P35498,P35498,11940708,"Three novel frameshift and seven nonsense mutations in the SCN1A gene have been identified in 14 Japanese patients with severe myoclonic epilepsy in infancy."
https://pharos.nih.gov/idg/targets/P35498,P35498,11254445,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,28381558,"Gain-of-function mutation of a voltage-gated sodium channel NaV1.7 associated with peripheral pain and impaired limb development"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,28162808,"the FGF13/Nav1.7 complex is essential for sustaining the transmission of noxious heat signals"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,28103821,"Genetic polymorphisms of SCN9A are associated with protection for severe neuropathy induced by oxaliplatin in digestive cancer."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,27821467,"the results of this study provide mechanistic evidence for a time-dependent increase in intracellular [Ca2+]i and energetic compromise in the neurites of dorsal root ganglia neurons expressing G856D mutant Nav1.7 channels."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,27747863,"The four congenital insensitivity to pain families, while not closely related, belong to the same ethnic group and clan, and the SCN9A mutation may be specific, if not unique to this group"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,27529686,"Results indicate that Nav 1.7 promotes gastric cancer progression through MACC1-mediated upregulation of NHE1."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,27503742,"A novel Nav1.9 mutation, p.Arg222His, was identified in patients with early-onset pain in distal extremities including joints and gastrointestinal disturbances, but was absent from an asymptomatic blood relative."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,27413160,"This study showed that gain-of-function attributes at the channel level and differential effects of physiologically relevant thermal stimuli on the excitability of DRG neurons expressing mutant and WT Nav1.7 channels, suggesting a cellular mechanism for warmth-triggered pain episodes in Erythromelalgia patients."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,27311819,"This is the first study to demonstrate that binding of ProTx-II to the lipid membrane is directly linked to its potency as an hNaV1.7 channel inhibitor."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,27162340,"Mutant cycle analysis with modified saxitoxins reveals specific interactions critical to attaining high-affinity inhibition of human NaV1.7."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,27129258,"report the engineering of highly potent and selective inhibitors of the Nav1.7 channel based on tarantula ceratotoxin-1 (CcoTx1). We utilized a combination of directed evolution, saturation mutagenesis, chemical modification, and rational drug design to obtain higher potency and selectivity to the Nav1.7 channel"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,26920677,"Patients with the SCN9A mutation with inherited erythromelalgia were characterized for the pain phenotype among individuals."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,26861708,"We exploited existing technologies in a novel manner to identify selective antagonists of NaV1.7. A full-deck high-throughput screen was developed for both NaV1.7 and cardiac NaV1.5 channels using a cell-based membrane potential dye FLIPR assay"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,26752484,"Postoperative pain was affected by SCN9A genetic variability in gynecological surgical patients."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,26634308,"Nav1.7 deletion has profound effects on gene expression, leading to an upregulation of enkephalin precursor Penk mRNA and met-enkephalin protein in sensory neurons."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,26486037,"We report the case of a 6-year-old girl with a SCN9A mutation who presented with both gain of function and loss of function phenotypes, including congenital corneal anesthesia."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,26168879,"These findings provided evidence that the variability of basal pain sensitivity was associated with SCN9A polymorphisms in the general population."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,25995458,"Novel SCN9A mutations altering Nav1.7 channel activation were found families with inherited erythromelalgia, paroxysmal extreme pain disorder and congenital insensitivity to pain."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,25957174,"the activity of mutant Nav1.7 channels in smooth muscle cells of skin vasculature and innervating sensory and sympathetic fibers contribute to the skin reddening"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,25585270,"Association of SCN9A variants with neuropathic pain and pain severity suggests a role of SCN9A in the disease etiology of neuropathic pain"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,25575597,"Nav1.7 mutations are associated with pain syndromes including erythromelalgia."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,25285947,"The novel p.L1612P Nav1.7 mutation expands the paroxysmal extreme pain disorder spectrum with a unique combination of clinical symptoms and electrophysiological properties"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,25240195,"PKC can increase sodium resurgent currents through phosphorylation of a conserved Serine residue located in the domain III-IV linker of hNav1.7"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,25209274,"Sodium channel Nav1.7, encoded by SCN9A, is expressed in DRG neurons and regulates their excitability."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,25008557,"NaV1.7 is expressed in both dorsal root ganglion neurons and pancreatic beta cells.Vulnerability of dorsal root ganglia neurons due to NaV1.7 mutations increases risk of neuropathy."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,24866741,"Our study demonstrates an example of predicting the treatment effect of mexiletine in patients suffering from a specific gain-of-function mutation in NaV1.7"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,24820863,"The co-segregation of the I739V variant in the affected members of the family provides evidence, for the first time, that paroxysmal itch can be related to a mutation in sodium channel gene."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,24401712,"This study show a linear correlation between the level of Nav1.7 conductance and current threshold in DRG neurons."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,24311784,"persistent and resurgent currents are likely to determine whether a mutation in Nav1.7 leads to IEM or PEPD."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,24202110,"Recent studies have shown that mutations in the SCN9A gene are the cause of a subgroup of idiopathic small fiber neuropathies and that polymorphisms of SCN9A are associated with an increase in susceptibility to pain."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,24082113,"Data indicate that micro-SLPTX-Ssm6a, a unique 46-residue peptide from centipede venom, potently inhibits NaV1.7."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,23986482,"EGF/EGFR-mediated upregulation of Nav1.7 is necessary for invasive behaviour in these cells."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,23895530,"Role of the SCN9A mutations in genetic epilepsy with febrile seizures plus and Dravet syndrome"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,23874707,"A working link between nociception and olfaction via Nav1.7 in the gain-of-function direction."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,23850641,"This study demonstrated that a variant of NaV1.7 associated with painful neuropathy depolarizes resting membrane potential and produces an enhanced inward current during interspike intervals, thereby contributing to DRG neuron hyperexcitability"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,23836888,"a novel regulatory mechanism that utilizes CRMP2 SUMOylation to choreograph NaV1.7 trafficking."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,23596073,"We identified a novel homozygous mutation in SCN9A from 2 Japanese families with autosomal recessive hereditary sensory and autonomic neuropathy type IId."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,23536180,"Structural and functional demonstration of the importance of radial tuning of the sodium channel S6 helix for the channel activation."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,23450472,"More patients have suffered dyskinesis pain. A 3448 (C/T) mutation of SCN9A gene may be related to pathogenesis of pain in Parkinsonism."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,23383113,"A novel SCN9A mutation responsible for primary erythromelalgia and is resistant to the treatment of sodium channel blockers."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,23364568,"Patients carrying the SCN9A 3312Tallele presented with lower postoperative pain sensitivity in the presence of a similar surgical pain stimulus"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,23292638,"2 gain-of-function mutations in the 4th domain of Nav1.7, A1746G & W1538R, caused hyperpolarization and affected age of erythromelalgia onset."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,23280954,"In small-fiber neuropathy, [isoleucine]228[methionine] variant Nav1.7 channel contributes to impaired regeneration and degeneration of sensory axons."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,23232607,"This review reveled the evidence that Na(V)1.7 is a major contributor to pain signalling in humans."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,23149731,"Structural modelling reveals that Na(v)1.7-S241T is ~2.4 A apart from V400M in the folded channel, and thermodynamic analysis demonstrates energetic coupling of V400M and S241T during activation."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,23129781,"We also found a splicing junction variant of SCN91 in all 19 patients WITH enital insensitivity to pain"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,23102778,"These data strongly suggest that pain perception in at least a subset of patients with interstitial cystitis/bladder pain syndrome is influenced by the rs6746030 polymorphism in the SCN9A voltage-gated sodium channel."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,23006801,"No association between a non-synonymous polymorphism in SCN9A and chronic widespread pain was observed in multiple population-based cohorts."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,22911851,"Splicing can change the way that Na(V) channels interact with beta subunits."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,22875917,"The results of this study suggested that Sodium channel Na(v)1.7 is essential for lowering heat pain threshold after burn injury."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,22539570,"The I739V Nav1.7 variant in a patient with biopsy-confirmed idiopathic small fiber neuropathy impairs slow-inactivation within dorsal root ganglion neurons and increases their excitability."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,22348792,"In this group of Mexican women, a disabling form of fibromyalgia is associated with a SCN9A sodium channel gene variant, raising the possibility that patients with severe fibromyalgia may have a dorsal root ganglia sodium channelopathy."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,22286749,"Description of a novel syndrome of distal pain, dysautonomia, small hands and small feet in a kindred with a novel missense SCN9A mutation that causes multiple gain-of-function changes in NaV1.7, including markedly enhanced persistent current."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,22136189,"results demonstrate intra- and interfamily phenotypic diversity in pain syndromes produced by a gain-of-function variant of NaV1.7."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,22033523,"We present a severe case of progressive primary erythromelalgia caused by a new de novo heterozygous missense mutation (c.2623C>G) of the SCN9A gene which substitutes glutamine 875 by glutamic acid (p.Q875E). To our knowledge, this mutation has not been previously reported in the literature. [review]"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,21984269,"Loss-of-function mutations in Na(v)1.7 are extremely rare, and invariably cause congenital inability to perceive pain (Review)"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,21939494,"Data suggest that mutations in SCN9A may be cause partial deletion of pain perception, and the novel polymorphism V1104L may have a predictive role in the pain sensation of healthy individuals."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,21715690,"Fine-tuning of immature dendritic cell (DC)functions by voltage-gated sodium channel Nav1.7 emerges as a new regulatory mechanism modulating migration and cytokine responses of DC subsets."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,21705421,"This study suggested that NS-Del channels can increase neuronal excitability at potentials where slow inactivation has not overwhelmed the effects of enhanced activation and the persistent currents that facilitate the generation of action potentials."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,21698661,"Gain of function mutations in sodium channel Nanu1.7 which render dorsal root ganglion neurons hyperexcitable and are present in a substantial proportion of patients meeting strict criteria for idiopathic small fiber neuropathy."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,21441906,"Na(v)1.7 is not only necessary for pain sensation but is also an essential requirement for odour perception in both mice and humans"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,21232038,"Depolarizing pulses that increased slow inactivation of Na(v)1.7 voltage-gated sodium channels also reduced lidocaine inhibition."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,21115638,"The paroxysmal extreme pain disorder associated Nav1.7 missense mutations M1627K, T1464I and V1299F increase Navbeta4 peptide-mediated resurgent sodium currents, in contrast to the erythromelalgia associated I848T and L858H Nav1.7 missense mutations."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,21094958,"A heterozygous change of n.4648 T-C in exon 27 caused W1550R, affecting a highly conserved amino acid, predicting damage in the transmembrane S2 region, repeat IV.SCN9A mutations cause pain syndromes other than IEM & PEPD."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,21031562,"R1150W amino acid change in the Na(V)1.7 alpha-chain is involved in genetic susceptibility to pain, but it does not appear to have a major role in osteoarthritic-specific pain."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,20959280,"We present a PEM case with R1150W polymorphism in SCN9A and a five-year remission was achieved by chemical lumbar sympathectomy (CLS)."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,20692858,"Congenital insensitivity to pain was associated with two novel SCN9A mutations which most likely resulted in a Nav1.7 channelopathy."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,20635406,"This study has identified critical amino acids needed for the normal subcellular localization and function of Na(v)1.7."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,20628234,"This mutation expands the body of evidence supporting the critical role of the Na1.7 channel in the perception of pain."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,20529324,"Na v 1.7 sodium channel may play a significant role in inflammatory dental pain."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,20478850,"This study shows that a change in relative expression of splice isoforms can contribute to time-dependent manifestation of the functional phenotype of a sodium channelopathy."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,20429905,"Results provide evidence for differential roles of the DIII/S4-S5 linker N- and C-termini in channel inactivation and activation, and demonstrate the cellular basis for pain in patients carrying these mutations."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,20379614,"Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,20212137,"Individuals experience differing amounts of pain, per nociceptive stimulus, on the basis of their SCN9A rs6746030 genotype."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,20212137,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,20146699,"several different disease manifestations arising from changes within the Na(v)1.7 channel (Review)"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,20074229,"Despite the fact that the SCN9A gene is an excellent candidate, we did not find evidence that it plays a major role in familial complex regional pain syndrome"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,20038812,"study showed that a paroxysmal extreme pain disorder mutation in the Nav1.7 channel, a paramyotonia congenita mutation in the Nav1.4 channel & a long-QT3/SIDS mutation in the NAV1.5 channel all increased the amplitude of resurgent sodium currents"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,20033988,"The results suggested that polymorphisms( R1150W) in the Na(V)1.7 channel may influence nociceptor excitability."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,19800314,"inherited form of erythromelalgia mutation L823R, which introduces an additional positive charge into the S4 voltage sensor of domain II, was characterized."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,19763161,"This study provides evidence for a role of SCN9A in human epilepsies, both as a cause of febrile seizure and as a partner with SCN1A mutations."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,19763161,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,19699781,"In trigeminal neuralgia (TN) there is a reduction in the expression of Nav1.7 and an increase in the expression of Nav1.3, Nav1.8 expression not significantly different; TN can be, at least in part, a channelopathy."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,19633428,"the additive effects observed on ramp currents from exon 5 splicing and the PEPD mutation (I1461T) are likely to impact the disease phenotype"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,19557861,"study reports a novel Nav1.7 mutation (V400M) in a three-generation Canadian family with inherited erythromelalgia in which pain is relieved by carbamazepine"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,19304393,"Here we describe a woman with insensitivity to pain with two novel mutations in the SCN9A gene, coding for the Nav1.7 channel."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,18978189,"Na(V)1.7 is expressed in aorta after balloon injury, suggesting a potential role for Na(V)1.7 in the progression of intimal hyperplasia"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,18945915,"Erythromelalgia and paroxysmal extreme pain disorder mutants(Nav1.7 A1632E)are part of a physiological continuum that can produce a continuum of clinical phenotypes."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,18803825,"Met1627Lys mutant SCN9A channels render dorsal root ganglion neurons hyperexcitable and provide a link between altered channel biophysics and pain in paroxysmal extreme pain disorder."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,18676988,"Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,18599537,"This study demonstrated that mutations within D3/S4-S5 affect inactivation of Nav1.7 in a residue-specific manner and disruption of the fast-inactivated state by these mutations can be more moderate than previously indicated."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,18518989,"two missense mutations in Nav1.7 in a family with erythermalgia; one of the two variants (L858F) is causal for erythermalgia; the second variant (P610T) may modify the phenotype"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,18439623,"variations of SCN9A can lead to complete inability to sense pain"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,18439623,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,18426592,"the increased axonal expression and augmentation of Nav1.7 at intact and remodeling/demyelinating nodes within the painful human dental pulp"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,18347287,"We detected a low SCN9A mutation rate in patients with primary erythermalgia suggesting that pain syndromes in the skin may have a polygenic basis"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,18337362,"alternative splicing of human Na(v)1.7 can specifically modulate the biophysical properties and cAMP-mediated regulation of this channel"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,18171466,"The isoleucine-136-valine substitution alters channel gating and kinetic properties, contributing to erythromelalgia."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,18079277,"State- and use-dependent block of neuronal Nav1.7 voltage-gated Na+ channel isoforms by ranolazine is reported."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,18070140,"review: Congenital Indifference to Pain patients assessed are homozygous or compound heterozygous for nonsense mutations at various locations throughout SCN9A, resulting in an early stop codon"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,18070139,"review: a series of SCN9A mutations resulting in gain-of-function phenotypes presenting with the phenotype of enhanced pain sensitivity."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,18060017,"highlights of recent developments and discussion of the critical role of Na(v)1.7 in pain sensation in humans [review]"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,18036246,"VGSC activity has a significant intermediary role in potentiating effect of EGF in human prostate cancer"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,17985268,"This study describe a boy with erythermalgia whose painful attacks began in infancy. We found a novel mutation of SCN9A."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,17950472,"The contribution of Na(v)1.7 to acquired and inherited pain states and the absence of motor, cognitive and cardiac deficits in patients lacking this channel make it an attractive target for the treatment of neuropathic pain."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,17928139,"In rectal hypersensitivity, Na(v)1.7 immunoreactive nerve fibres were significantly increased in mucosal, sub-mucosal, and muscle layers"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,17597096,"A stop codon mutation in SCN9A causes lack of pain sensation."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,17470132,"identified 10 mutations in the SCN9A gene encoding the sodium channel protein Nav1.7 in congenital indifference to pain"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,17430993,"Mutations in SCN9A may mediate variabiilty in lidocaine sensitivity in erythromelalgia patients."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,17410110,"A patient represents a typical case of juvenile onset primary familial erythromelalgia, a rare disorder that has been shown in some patients to be caused by a mutation to the SCN9A gene."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,17404832,"results suggest that the enhancement of TTX-sensitive sodium current density in differentiated NG108-15 cells is mainly due to the increase in the expression of the TTX-sensitive voltage-gated Na+ channel, NaV1.7"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,17294067,"A Taiwanese family with the characteristic features of erythromelalgia is described. Genetic linkage studies established that the disease locus maps to human chromosome 2 and a novel mutation SCN9A(I136V)"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,17167479,"data suggest that SCN9A is an essential and non-redundant requirement for nociception in humans"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,17167479,"An SCN9A channelopathy causes congenital inability to experience pain"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,17135418,"Ala863Pro mutant Nav1.7 channels produce hyperexcitability in dorsal root ganglia neurons, which contributes to the pathophysiology of erythromelalgia/erythermalgia."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,17008310,"the linker between S4 and S5 in domain I of Nav1.7 modulates gating of this channel, and a larger side chain at position 241 interferes with its gating mechanisms"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,16988069,"These results provide a physiologic basis for the linkage to erythermalgia of an Na(v)1.7 mutation that substitutes one uncharged residue for another within an S4 segment of the channel."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,16392115,"A single amino acid substitution (L858F) in the DIIS4-S5 linker of Na(v)1.7 was present in two children whose parents were asymptomatic. The asymptomatic father was genetically mosaic for the mutation."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,16216943,"primary erythermalgia may be caused by hyperexcitability of nav1.7."
https://pharos.nih.gov/idg/targets/Q15858,Q15858,16088330,"Nav1.7 is the VGSCalpha most strikingly upregulated (approximately 20-fold) in prostate neoplasms"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,15955112,"detected missense sequence variants in SCN9A to be present in primary erythermalgia patients"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,15929046,"familial erythromelalgia is a channelopathy caused by mutations in the gene encoding the Na(v)1.7 sodium channel which lead to altered channel function"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,15385606,"We show that mutations in Na(v)1.7 associated with erythermalgia produce a hyperpolarizing shift in activation and slow deactivation, and cause an increased amplitude of the current produced by Na(v)1.7 in response to slow, small polarizations"
https://pharos.nih.gov/idg/targets/Q15858,Q15858,14985375,"mutations in SCN9A cause primary erythermalgia"
https://pharos.nih.gov/idg/targets/Q99250,Q99250,28518218,"Pathogenic, likely pathogenic, and benign variants in SCNs were identified using databases of sodium channel variants. Benign variants were also identified from population-based databases. Eight algorithms commonly used to predict pathogenicity were compared. In addition, logistic regression was used to determine if a combination of algorithms could better predict pathogenicity."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,28379373,"clinical and experimental data suggest a correlation between age at disease onset, response to sodium channel blockers and the functional properties of mutations in children with SCN2A-related epilepsy."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,27538648,"This study demonstrated the association of SCN2A rs1864885 A > G, in Japanese childhood encephalopathy patients."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,27153334,"Data indicate eight new cases with overlapping duplications at 2q24 and SCN3A was not involved in duplication, suggesting that having an extra copy of SCN2A has an effect on epilepsy pathogenesis."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,26993267,"The most frequently mutated gene in early-onset seizure and severe developmental delay disorders was SCN2A (11 patients, 3%), occurring de novo in all patients."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,26645390,"Our findings broaden the clinical spectrum observed with SCN2A gain-of-function mutations, showing that fairly different biophysical mechanisms can cause a convergent clinical phenotype of neonatal seizures and later onset episodic ataxia."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,26637798,"This study provide the evidence SCN2A mutation releate to Autism Spectrum Disorder."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,26555645,"We argue that very rare, loss-of-function mutations at SCN2A act in a moderately penetrant manner to increase the risk of developing several neuropsychiatric disorders including seizure disorders, intellectual disability, autism and schizophrenia."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,26311622,"Mutations in SCN1A and SCN2A are a predisposing factor of acute encephalopathy with biphasic seizures and late reduced diffusion"
https://pharos.nih.gov/idg/targets/Q99250,Q99250,26291284,"SCN2A is the second most common cause of epilepsy of infancy with migrating focal seizures"
https://pharos.nih.gov/idg/targets/Q99250,Q99250,25998125,"Two lysine residues (residues 105-106)of AnkG are critical for Nav1.2 but not KCNQ3 channel binding."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,25961639,"Findings provide convergent evidence that a common polymorphism in SCN2A accounts for significant interindividual variability in human general cognitive ability, possibly by modulating prefrontal cortex physiology"
https://pharos.nih.gov/idg/targets/Q99250,Q99250,25818041,"Epileptic encephalopathy related to mutations in the SCN2A genes."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,25459969,"A heterozygous mutation (c.3631G > A; p.E1211K) was identified in exon 21 of SCN2A gene. This is the first case of SCN2A mutation identified in Chinese."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,25457084,"Case suggests that SCN2A mutations might predispose children to repetitive encephalopathy with variable clinical and imaging findings."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,25155934,"the mechanism of AED resistance remains uncertain, which led us to evaluate the impact of polymorphisms of the SCN1A, SCN2A and ABCC2 genes on the AED response in Chinese Han patients with epilepsy in the present study."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,24718902,"identified common variants in SCN2A that, in the context of schizophrenia and risk for schizophrenia, show substantial and consistent associations with broad cognitive performance, brain physiology, and mRNA expression in the brain."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,24659627,"mutation of SCN2A is associated with a range of epilepsy phenotypes including severe infantile-onset epilepsy"
https://pharos.nih.gov/idg/targets/Q99250,Q99250,24579881,"Exome sequencing reveals a de novo mutation in SCN2A linked to a genetically heterogeneous disorder with epilepsy and intellectual disability, expanding the phenotype of SCN2A mutations."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,24337656,"sodium channel polymorphisms are associated with epilepsy"
https://pharos.nih.gov/idg/targets/Q99250,Q99250,24220630,"Following SCN2A knockdown, the concentration of Cu-Zn SOD declined and the si-SCN2A vector group showed a repeated discharge."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,23935176,"SCN2A mutations are an important genetic cause of Ohtahara syndrome. Given the wide clinical spectrum associated with SCN2A mutations, genetic testing for SCN2A should be considered for children with different epileptic conditions."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,23859570,"Our data from the Hong Kong and Malaysia cohorts showed no significant allele, genotype and haplotype association of polymorphisms in the SCN1A, SCN2A, and SCN3A genes with drug responsiveness in epilepsy."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,23827426,"An SCN2A missense mutation is associated with infantile spasms and bitemporal hypometabolism."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,23758435,"Mutation of SCN2A induces neuronal hyperexcitability, resulting in infantile epilepsy with favorable outcome"
https://pharos.nih.gov/idg/targets/Q99250,Q99250,23550958,"study identified a de novo SCN2A mutation as the etiology for Ohtahara syndrome in monozygotic twins associated with a unique dentate-olivary dysplasia in the deceased twin"
https://pharos.nih.gov/idg/targets/Q99250,Q99250,23360469,"Identification of a novel SCN2A mutation in a family with infantile seizures with onset between 6 and 8 months provides further confirmation that this gene is involved in families with a delayed age of onset."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,23016767,"This study demonistrated that associated with a duplication of the SCN2A and SCN3A gene cluster on 2q24 in patient with early onset epilepsy."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,22677033,"This study demonistrated the detailed functional analysis of Na(v)1.2 mutant, R1312T, which was originally found in a child with Dravet syndrome."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,22591750,"This finding suggests that SCN2A mutation is a predisposing factor for acute encephalopathy."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,22525008,"The results of this study shown that both A1685V (GEFS+) and A1685D (SMEI) mutant Nav1.1 channels are characterized by complete loss of function when they are expressed alone"
https://pharos.nih.gov/idg/targets/Q99250,Q99250,22495306,"association of the gene SCN2A, previously identified in epilepsy syndromes, with the risk of autism"
https://pharos.nih.gov/idg/targets/Q99250,Q99250,22029951,"Functional studies of SCN2A mutations show that they can cause divergent biophysical defects in Na(V)1.2 and impair cell surface expressions[review]"
https://pharos.nih.gov/idg/targets/Q99250,Q99250,21762452,"Environmental enrichment from birth reduces spontaneous seizures and neuronal damage in the Q54 model of temporal lobe epilepsy."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,21439835,"Thermodynamic and structural studies of Calmodulin (CaM)-Na(v)1.2(IQp) interactions show that apo and (Ca(2+))(4)-CaM adopt distinct conformations that both permit tight association with Na(v)1.2(IQp) during gating."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,21377452,"We studied the developmental changes of Na(v)1.1 and Na(v)1.2 in the human hippocampus and temporal lobe"
https://pharos.nih.gov/idg/targets/Q99250,Q99250,21156207,"Genetic variants in the voltage-gated ion channel SCN2A dramatically influence the phenotype of mice carrying an SCN1A mutation as well as the seizures caused by the SCN1A mutation."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,20602612,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q99250,Q99250,20379614,"Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q99250,Q99250,20371507,"Transient expression of seizures occur due to a gain-of-function of mutant Na(V)1.2 channel."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,20346423,"Deletions in SCN2A gene is associated with autistic features and developmental delay."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,19786696,"de novo mutations SCN2A-E1211K, -I1473M, and -R102X indicate that SCN2A is an etiologic candidate underlying a variety of intractable childhood epilepsies"
https://pharos.nih.gov/idg/targets/Q99250,Q99250,19783390,"This finding suggests that both nonsense mutations and missense SCN2A mutations cause Dravet syndrome."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,19743470,"The direct effect of heat on Nav1.2 channels localized to the site of action potential initiation potentially causes a profound increase in neuronal excitability. This is likely to contribute to febrile seizure genesis."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,19738391,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q99250,Q99250,19694741,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q99250,Q99250,19465131,"Data demonstrate that the two N-terminal alternatively spliced FGF14 variants, FGF14-1a and FGF14-1b, differentially regulate currents produced by Nav1.2 and Nav1.6 channels."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,19401682,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q99250,Q99250,19270815,"Observational study of gene-disease association, gene-gene interaction, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q99250,Q99250,19129176,"Clinically significant mutations identified in the C-terminal region of NaV1 sodium channels cluster in the helix I-IV interface and the helix II-III interhelical segment or in helices III and IV of the NaV1.2 (1777-1882) structure."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,18784617,"The association of antiepileptic drugs responsiveness with genetic polymorphisms was investigated and any association with mRNA expression of the neuronal sodium channels was correlated."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,18784617,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q99250,Q99250,18479388,"SCN2A gene mutations are associated with inherited benign neonatal-infantile epilepsy."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,17805013,"Nav1.2 immunostaining was not observed along demyelinated axons in chronic lesions but was expressed by scar and reactive astrocytes within the plaque."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,17715289,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q99250,Q99250,17715289,"Allele frequencies of both the D2S111 and the D2S124 polymorphisms of the SCN2A gene were not significantly different between cases with a specific idiopathic generalized epilepsy subtype (with generalized tonic-clonic seizures) and healthy controls."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,17641256,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q99250,Q99250,17641256,"In south china, the R188W mutation of the SCN2A gene not releate to children with febrile seizures."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,17544618,"Characterization of 5' untranslated regions SCN2A, and identification of cis-conserved noncoding sequences"
https://pharos.nih.gov/idg/targets/Q99250,Q99250,17467289,"analysis of neonatal & adult splice forms of NaV1.2 with a benign familial neonatal-infantile seizures mutation; developmentally regulated NaV1.2 splicing may be one mechanism that counters the normally high excitability of neonatal neurons"
https://pharos.nih.gov/idg/targets/Q99250,Q99250,17386050,"two large families with benign familial neonatal-infantile seizure (BFNIS) and novel SCN2A mutations; the families had 12 & 9 affected individuals, respectively, with phenotypes consistent with BFNIS; two mutations were discovered in SCN2A (E430Q; I1596S)"
https://pharos.nih.gov/idg/targets/Q99250,Q99250,16914293,"The SCN2A gene was tested for a possible role in hippocampal abnormalities in familial mesial temporal lobe epilepsy. We conclusively ruled out the SCN2A gene as a candidate in FMTLE."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,16847056,"Data show that the varied effects of beta1 and beta2 on Nav1.5 and Nav1.2 gating are apparently synergistic and highlight the complex manner, through subunit- and sugar-dependent mechanisms, by which Nav activity is modulated."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,16464983,"Genetic interaction between the combined mild alleles of monogenic epilepsy genes KCNQ2 and SCN2A1 results in severe epilepsy in transgenic mice."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,16052353,"Although data suggest that SCN2A1 activity does not directly influence membrane potential, intracellular Ca(2+) release, or proliferation in normal human pulmonary artery smooth muscle cells, its physiological functions remain unresolved."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,15316014,"Calmodulin mediates Ca2+ sensitivity of Nav1.2 and Nav1.5 sodium channels"
https://pharos.nih.gov/idg/targets/Q99250,Q99250,15249644,"a role for the hemizygous deletion of not one but two sodium channel genes (SCN1A and SCN2A) in another complicated and more severe epileptic phenotype."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,15028761,"We found a nonsense mutation of SCN2A in a patient with intractable epilepsy and severe mental decline. The phenotype is like severe myoclonic epilepsy in infancy but distinct because of partial epilepsy, delayed onset and no temperature sensitivity"
https://pharos.nih.gov/idg/targets/Q99250,Q99250,12610651,"in autism families, the variant R1902C in SCN2A is located in the calmodulin binding site and was found to reduce binding affinity for calcium-bound calmodulin."
https://pharos.nih.gov/idg/targets/Q99250,Q99250,12165424,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q99250,Q99250,11738931,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,28882890,"identified two novel native phosphorylation sites in the C terminus of NaV1.5 that impair FGF13-dependent regulation of channel inactivation and may contribute to CaMKIIdeltac-dependent arrhythmogenic disorders in failing hearts."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,28552773,"BIMU8 is a potent blocker of hERG, NaV1.5 and CaV1.2 cardiac ion channels, inducing cardiac arrhythmias."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,28341781,"Brugada syndrome patients with SCN5A mutations exhibit more conduction abnormalities on ECG."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,28262340,"A gain-of-function missense mutation in SCN5A is associated with ventricular arrhythmias and atrial fibrillation."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,28191886,"Nav1.5 is hyperacetylated on K1479 in the hearts of patients with cardiomyopathy and clinical conduction disease."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,28085969,"One common intronic variant in SCN5A is linked with risk of Ventricular Fibrillation caused by first ST-Segment Elevation Myocardial Infarction."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,28069705,"Almost 2% of ARVD/C patients harbour rare SCN5A variants. For one of these variants, we demonstrated reduced sodium current, Nav1.5 and N-Cadherin clusters at junctional sites. This suggests that Nav1.5 is in a functional complex with adhesion molecules, and reveals potential non-canonical mechanisms by which Nav1.5 dysfunction causes cardiomyopathy."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,28018021,"Compound heterozygous variants c.101G>A and c.3832G>A in the SCN5A gene were found in the complete heart block affected child and were not found in unaffected family members."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,28011106,"It might be important to suspect the coexistence of DCM and LQT3 (which is rare according to previous articles) in cases with this novel SCN5A missense mutation"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,27988371,"Novel Single Nucleotide Polymorphism at SCN5A implicate gene regulatory dysfunction in QT prolongation in African and Hispanic Americans."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,27919765,"In patients with Brugada syndrome carried SCN5A mutations using cardiovascular magnetic resonance with late gadolinium enhancement may serve as early marker for evolution of a Cardiomyopathic phenotype over time."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,27861438,"Clinically relevant cardiotoxicity of domperidone and metoclopramide corresponds to a rather potent and local anesthetic-like inhibition of cardiac Na channels including Nav1.5."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,27810048,"There are 12 loci possibly associated with BrS, the most common of which is the sodium voltage-gated channel alpha subunit 5 (SCN5A), resulting in hNav1.5 loss of function leading to type 1 BrS."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,27784737,"We conclude that Gentamycin and PTC124 are unlikely to present an effective treatment for patients carrying the loss-of-function SCN5A gene mutations examined in this study."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,27736720,"Pathogenic variants in the SCN5A gene modify electrical excitability of sodium cannel that causes an imbalance in the currents of the different ions involved in the contraction process of the cardiomyocytes and induce ventricular remodeling and Dilated cardiomyopathy."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,27733495,"Ranolazine blocks INaL in experimental models of LQT3 harboring the SCN5A-D1790G mutation and shortened the QT interval of LQT3 patients."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,27666479,"trifluoperazine blocks hNav1.5 current in concentration-, state- and use-dependent manners rather than via calmodulin inhibition"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,27625342,"Variants in the core promoter region and the transcription regulatory region of SCN5A were identified in multiple arrhythmia phenotypes, consistent with the idea that altered SCN5A transcription levels modulate susceptibility to arrhythmias."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,27577874,"rs3922844 was associated with QRS duration and SCN5A expression, two novel QRS loci were identified using transethnic meta-analysis, and a significant proportion of QRS-SNP associations discovered in populations of European descent were transferable to African Americans when adequate power was achieved"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,27554632,"Data from this study demonstrate that SCN5A gene variants have important role in the etiopathogenesis of dilated cardiomyopathy and hypertrophic cardiomyopathy."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,27465321,"These results suggested that neferine can block Nav1.5 channels under the open state and inactivating state and it is an open channel blocker of Nav1.5 channels."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,27381756,"There is a strong genotype-phenotype correlation with complete penetrance for Brugada syndrome, Long QT syndrome, or Cardiac conduction defect in the largest family harboring SCN5A-E1784K mutation described so far. Phenotype of LQTS is present during all decades of life, whereas CCD develops with increasing age. Phenotypic overlap may explain the high event rate in carriers."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,27364017,"The Nav1.5 channel interacts with the MAGUK protein, CASK, which controls its surface expression at the lateral membrane of cardiomyocytes by regulating ion channel trafficking."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,27287068,"The SCN5A variants R568H and A993T can be classified as pathogenic LQTS3 causing mutations."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,27281089,"This initial functional study for SCN5A mutation in the Chinese SUNDS victim revealed that the acidosis aggravated the loss of function of mutant channel R1512W"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,27160185,"the sigma-1 receptor and the nNav1.5 channel formed a physical, functional complex"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,27108952,"the mutantinduced changes contributed to the loss of function of Nav1.5 channels, which indicates that the p.D1690N variant may have a pathogenic role in Brugada syndrome."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,27063795,"misregulation of the alternative splicing of SCN5A may contribute to a subset of the cardiac dysfunctions observed in myotonic dystrophy."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,27000037,"Tetrodotoxin-sensitive alpha-subunits of voltage-gated sodium channels are relevant for inhibition of cardiac sodium currents by local anesthetics."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,26965448,"Molecular and pharmacological characterization of the SCN5A p.I141V mutation provide new evidence supporting the association of this mutation with exercise-induced polymorphic ventricular arrhythmias. These data also demonstrate that flecainide may serve as an effective treatment for the defect in Nav 1.5 that leads to an increased sodium window current."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,26961874,"Identifies alphaB-crystallin as a new binding partner for Nav1.5. alphaB-Crystallin interacts with Nav1.5 and increases INa by modulating the expression level and internalization of cell surface Nav1.5 and ubiquitination of Nav1.5, which requires the protein-protein interactions between alphaB-crystallin and Nav1.5 and between alphaB-crystallin and functionally active Nedd4-2."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,26921764,"Brugada syndrome patients with Life-Threatening Arrhythmias underwent genetic testing, were genotype positive with SCN5A rare variants, whereas the SCN5A-negative patients remained asymptomatic."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,26916278,"SCN5A genetic variants are linking to different cardiomyopathies (Review)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,26861708,"We exploited existing technologies in a novel manner to identify selective antagonists of NaV1.7. A full-deck high-throughput screen was developed for both NaV1.7 and cardiac NaV1.5 channels using a cell-based membrane potential dye FLIPR assay"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,26820605,"The present study demonstrated that a novel heterozygous missense mutation of A1055G in SCN5A led to 'loss-of function' of the sodium channels, and we suggest that it accounts for the arrhythmogenic characteristics of ERS."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,26801742,"The p.R1309H homozygous NaV1.5 mutation conferred both gain-of-function and loss-of-function effects on NaV1.5 channel activity. Reduction of a mutation-induced gating pore current by lidocaine suggested a therapeutic mechanism"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,26786162,"Nav1.5 N-terminal domain binding to alpha1-syntrophin increases membrane density of human Kir2.1, Kir2.2 and Nav1.5 channels"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,26746457,"Among laboratories there was low concordance in designating SCN5A and KCNH2 variants as pathogenic. In an unselected population, the putatively pathogenic genetic variants were not associated with an abnormal phenotype."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,26729167,"Alkaloids from Veratrum taliense Exert Cardiovascular Toxic Effects via Cardiac Sodium Channel Subtype 1.5"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,26718772,"Pharmacological or genetic blockade of Nav1.5 may serve as a potential anti-metastatic therapy for breast cancer."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,26639179,"In symptomatic patients with deleterious variants in SCN5A a permanent pacemaker and implantable cardioverter defibrillator therapy should be considered."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,26636939,"Role of Asparagines in Coupling the Pore and Votage-Sensor Domain in Voltage-Gated Sodium Channels"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,26496715,"Mutational screening identified 104 mutations (44% novel), i.e. 46 KCNQ1, 54 KCNH2 and 4 SCN5A mutations for long QT syndrome in China"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,26467377,"p.Gln1507-Lys1508-Pro1509del mutation, p.Arg222Ter nonsense mutation, and p.Met1498Arg mutation in the SCN5A gene in long-QT syndrome type 3, Brugada syndrome, and sick sinus syndrome, respectively, were found in the Iranian population."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,26452220,"Authors conclude that Nav1.5 is functionally active in cancer cells in breast tumors, enhancing growth and metastatic dissemination."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,26392562,"Data indicate that SCN5A variant (Nav1.5) p.H1849R affected interaction with fibroblast growth factor homologous factor (FHFs)."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,26382759,"Results show that Fyn differentially modulates Nav1.5 channel splice variants. It phosphorylates Nav1.5 variants Q-del and Q-pre resulting in there hyperpolarizing and depolarizing shift. Fyn's activity is abolished in the presence of both variants."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,26361848,"The SCN5A channel predominates the cardiac sodium current and mutations in SCN5A are associated with multiple cardiac diseases. Review]"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,26304136,"a family with a history of atrial arrhythmias due to sick sinus syndrome and paralysis of the atrium; genetic study revealed the presence of the SCN5Ap.Arg219His variant"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,26282245,"SCN5A mutation in a patient with Sinus node dysfunction and epinephrine-induced QT prolongation was identified , which was an atypical phenotype for Long Qt Syndrome 3 ."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,26255078,"We investigated the frequency of the p.R1193Q substitution in > 4000 genomic DNA samples from 34 Asian, European, and African populations using TaqMan and/or APLP (amplified product length polymorphism) assays. Allele A (p.1193Q) was detected in most Asian populations, but was sporadically observed or absent in European and African populations. These results demonstrated that the p.R1193Q substitution is character"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,26209461,"Nav1.5 is encoded by the SCN5A gene that in its mutated form is implicated in various channelopathies, specifically at cardiac tissue level. (Review)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,26154754,"The prevalence of SCN5A mutations in the Chinese Han population in Taiwan may be lower than that reported in the Caucasian populations."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,26146998,"CC genotype of the rs11720524 polymorphism in the SCN5A gene encoding a subunit of the cardiac voltage-gated sodium channel occurred more frequently in the highly heterogeneous cardiac death cohort compared to the control population"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,26129877,"We found a rare SCN5A variant, R986Q, in patients with lone AF."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,26118593,"Demonstrated the prevalence of SCN5A mutations and polymorphisms in a Taiwanese population with Long QT Syndrome."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,26111534,"We identified an association between sinus node dysfunction, atrial arrhythmias, elevated or fluctuating poor pacemaker capture, and SCN5A mutations (5 heterozygous and 1 homozygous) that are predicted to cause severely compromised NaV1.5 function."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,26109178,"The H558R polymorphism in the SCN5A gene has been associated with the LQT3 syndrome and possibly can influence repolarization and depolarization of cardiac muscle cells."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,26031372,"SCN5A missense mutation is responsible for the atypical Brugada syndrome."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,26009199,"Current evidence shows that Cx43 plays a crucial role in organizing microtubules at the intercalated disc and thereby regulating the trafficking of the cardiac sodium channel NaV1.5 to the membrane"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,25998140,"SCN5A gene mutations that reduce sodium channel current may provide a mechanistic link between Atrioventricular nodal reentrant tachycardia and Brugada syndrome and predispose to expression of both phenotypes."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,25923670,"The splice variant and environmental factors affect the molecular phenotype of cardiac SCN5A-encoded sodium channel (Nav1.5), has implications for the clinical phenotype, and may provide insight into acidosis-induced arrhythmia mechanisms."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,25904541,"Data indicate that electrophysiology studies agree on the phenotypic manifestations of Brugada syndrome and Long-QT syndrome-associated voltage-gated sodium channel subunit alpha Nav1.5 (SCN5A) nonsynonymous single nucleotide variants (nsSNVs)."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,25871451,"An investigation of the association of the H558R polymorphism of the SCN5A gene with idiopathic cardiac conduction disorders."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,25829473,"Mutational analysis across all 29 exons in SCN5A of the proband and first-degree relatives of the family revealed that the proband inherited a compound heterozygote mutation in SCN5A, specifically p.A226V and p.R1629X from each parent. The study is the first to report a SCN5A compound heterozygote in a Singaporean Chinese family."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,25815641,"CaMKII phosphorylates SCN5A in vitro on 23 novel serine sites as was identified by mass spectrometry; reduced S516 phosphorylation has been found in human heart failure."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,25757662,"In a nonreferred nationwide Danish cohort of SIDS cases, up to 5/66 (7.5%) of SIDS cases can be explained by genetic variants in the sodium channel complex genes."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,25721215,"Fully-glycosylated state of Nav1.5 seems to determine its functionality whereas core-glycosylated forms might be transported to the plasma membrane through an unconventional Golgi-independent secretory route."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,25692452,"Modest differences in cardiotoxicity between local anesthetics, bupivacaine and ropivacaine, are compatible with subtle differences in their interaction with human cardiac SCN5A channels."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,25624448,"The findings suggest that the gating pore current generated by the R222Q and R225W mutations could constitute the underlying pathological mechanism that links Na(v)1.5 voltage-sensor domain (VSD) mutations with human cardiac arrhythmias and dilatation of cardiac chambers."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,25558681,"Mutation p.delKPQ 1505-1507 in SCN5A gene is risk factor not only of LQ-TS phenotype but also some of the carriers of this mutation have had LQ-TS and Brugada syndrome (combine phenotype)."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,25501501,"Interplay between R513 methylation and S516 phosphorylation of the cardiac voltage-gated sodium channel."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,25496128,"Ranolazine (50 muM) inhibited Na(V)1.5 currents in breast cancer cells."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,25443231,"SCN5A the gene that encode respectively a- and b-subunits of the cardiac fast voltage-gated sodium channel, have been linked to atrial fibrillation."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,25422141,"A calcium permeable channel in Nav1.5 was used to customize blockage of the channel and to identify binding sites."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,25401102,"Genetic examinations of the SCN5A gene at 6 positive patients showed 6 known polymorphisms, 8 new single nucleotide point (SNP) variants located at exons, and 12 new single nucleotide point variants located at introns"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,25370050,"CaM binds to the c-terminal of Na(v)1.5 with high affinity."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,25368329,"Data suggest a mechanism to link macrophage sodium channel alpha subunit SCN5A function to downstream signaling and regulation of transcription."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,25341504,"It is likely that the familial CACNA1C loss-of-function mutation contributes to Brugada syndrome phenotype and shorter QTc interval while the SCN5A mutation is associated with severe cardiac conduction defects."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,25210054,"A novel missense mutation (p.I141V) in a highly conserved region of the SCN5A gene, encoding the Nav1.5 sodium channel protein that cosegregated with the arrhythmia phenotype."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,25177937,"Data indicate that a significant association was found between the cardiac voltage-gated sodium channel (SCN5A) H558R polymorphism of exon 12 and Keshan disease (KSD)."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,25172307,"The N-terminus of myocardial NaV1.5 is devoid of the initiation methionine and is acetylated at the resulting initial alanine residue in end stage heart failure."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,25171853,"An 11-year-old girl on evaluation for syncope was found to have progressive sinus node dysfunction and His-Purkinje system disease with atrial standstill."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,25102755,"Association between p.E446K mutation in SCN5A gene and Dilated cardiomyopathy with mild left ventricular hypertrophy, progressive AV block, atrial fibrillation and congenital atrium septal defect in two generations was observed."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,25065297,"The common SCN5A variant, rs7629265, is associated with increased risk for atrial fibrillation among African Americans."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,25051102,"Two out of 46 (4.3%) AMI/VF+ patients revealed mutations that may be involved in Nav1.5 dysfunction and ventricular fibrillation."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,25010007,"A defined mechanism of SCN5A related arrhythmias."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,24956219,"FoxO1 is involved in the modulation of NaV1.5 expression in ischemic heart disease."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,24951663,"SCN5A variants is associated with cardiac conduction."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,24903439,"Case Report: p.Y1449C SCN5A mutation in a single family with a spectrum of cardiac phenotypes including conduction disease, Brugada syndrome and atrial arrhythmias."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,24871449,"High prevalence of the SCN5A E1784K mutation in school children with long QT syndrome living on the Okinawa islands."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,24815523,"Comparisons with other cardiomyopathy-associated NaV1.5 voltage sensor mutations revealed a pattern of abnormal voltage dependence of activation as a shared biophysical mechanism of the syndrome."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,24795344,"Myocytes sodium current densities of the R526H and S528A SCN5A mutants were significantly reduced compared with control."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,24768612,"Our study is the first to describe the deleterious effect of DM1 on clinical expression of a loss-of-function SCN5A mutation and to show a provoked BrS phenotype in a DM1 patient."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,24762805,"Familial sick sinus syndrome SCN5A mutational analysis indicated male predominance in the genetic screening of japanese patients."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,24756536,"reduced nNav1.5 expression significantly suppressed the proliferation and invasiveness of astrocytoma cells, indicating a new target in the molecular diagnosis and therapy of astrocytoma."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,24721456,"mutation rate and the arrhythmic risk are not different in the subgroups analyzed and the reason for this interindividual variability simply lies in the different anatomical location of the RVOT"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,24717670,"Mutations in SCN5A that would be predicted to generate increased Purkinje cell automaticity are associated with high-grade ventricular ectopy and reversible dilated cardiomyopathy."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,24703920,"Circulating levels of SCN5A variants are strongly associated with myocardial tissue levels in heart failure patients."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,24642470,"SCN10A variant rs6801957, which correlated with slowed cardiac conduction, was associated with reduced SCN5A expression."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,24613995,"About 2% of patients with irritable bowel syndrome carry loss of function mutations in SCN5A that disrupt NaV1.5 channel function."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,24599044,"In a Danish family suffering from long QT syndrome, a novel missense mutation in SCN5A, changing a leucine residue into a glutamine residue at position 1786 (L1786Q), was found to be present in heterozygous form co-segregating with prolonged QT interval."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,24582607,"We have identified a distal truncated SCN5A mutant associated with gain- and loss-of-function effects, leading to sick sinus syndrome and genetic arrhythmias."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,24581105,"SCN5A missense mutation found in patient with Brugada syndrome from Bangladesh."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,24573164,"SCN5A missense mutations lead to the electrocardiography abnormalities seen in patients with Brugada syndrome disease."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,24529773,"This first comprehensive genotyping for SCN5A and related genes in the Chinese Han population with sudden unexplained nocturnal death syndrome discovered 13 mutations."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,24476701,"Ajmaline response in SCN5A mutation may be adverse with conduction abnormalities in Brugada pattern."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,24463578,"integrating sequence-based information and secondary protein structures elements may help select highly potential variants in BrS before conducting time-consuming electrophysiological studies and two novel SCN5A mutations were validated"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,24445991,"it would be possible to identify and characterize rare variants in SCN5A that might predispose to lethal ventricular arrhythmias"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,24363796,"the mutation (p.D1816VfsX7) resulted in a severe truncation (201 residues) of the Nav1.5 C-terminus,confirming the key role of the C-terminal domain in the expression and function of the cardiac Na(+) channel"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,24360055,"A single-nucleotide polymorphism (SNP) associated with alterations in cardiac conduction patterns affects the transcriptional regulation of the sodium channel genes, SCN5A and SCN10A, predisposing for cardiac arrhythmias."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,24317018,"This finding may provide new evidence of the genetic pathogenesis of ARVD in Chinese patients, implying that the SCN5A gene should be screened in patients with ARVD and VT/VF."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,24300601,"Nav 1.5 mutations linked to dilated cardiomyopathy phenotypes"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,24295898,"Family members with R376C mutation had different phenotypes of sick sinus syndrome."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,24269159,"Brugada syndrome is linked to mutations in the SCN5A gene in approximately 20% of Brugada syndrome probands"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,24227891,"A1180V is a potential risk factor for dilated cardiomyopathy."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,24167619,"Electrophysiological characteristics of a SCN5A voltage sensors mutation R1629Q associated with Brugada syndrome."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,24140416,"Suggest a potential implication of Brugada syndrome in sudden death in myotonic dystrophy type 1, which may be related to missplicing of SCN5A."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,24112685,"Both gain and loss of function were found in SCN5A mutations in infantile fatal ventricular arrhythmias."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23995044,"Mutations in LQTS-susceptibility genes were found in 38 of 40 prenatal subjects undergoing genetic testing, including 6 with SCN5A."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23963187,"A1180V cardiac sodium channel mutation, expanding the spectrum of phenotypes resulting from this mutation in which biophysical study has shown a persistent late Na(+) current."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23955615,"A novel SCN5A (F1775Lfs*15) mutation was identified in patients with familial sick sinus syndrome."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23936059,"In women with Turner syndrome and a bQTc .432 ms, 7 had mutations in major Long QT syndrome genes (SCN5A and KCNH2) and one in a minor Long QT syndrome gene (KCNE2)."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23912080,"results show that protein arginine methyl transferase (PRMT)-3 and -5 methylate NaV1.5 in vitro, interact with NaV1.5 in human embryonic kidney (HEK) cells, and increase NaV1.5 current density"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23902689,"NaV1.5 colocalises with NHE-1 and caveolin-1 at the sites of matrix remodelling in invadopodia."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23893162,"Stabilization of the S4 segments DI-R2C but not DII-R2C speeds inactivation of Nav1.5."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23872634,"Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23853484,"Intronic variant in SCN5A gene seemed to be associated with sudden cardiac arrest especially in males."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23840796,"SCN5A 1493delK channels that reached cell membrane showed gain-of-function aspects."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23823228,"destabilized fast-inactivation and reduced charge immobilization in NaV1.5 at low pH are functionally related effects"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23791817,"Zebrafish expressing the human SCN5A-D1275N mutation, but not wild-type SCN5A, exhibit bradycardia, conduction-system abnormalities and premature death."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23714088,"Subjects with LQT-PM may have longer QTc intervals at rest and at peak exercise and all phases of the recovery period compared to controls. Those with homozygous SNPs (SCN5A 37%) had longer resting QTc intervals when compared to heterozygotes."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23692053,"Subtle alterations of Na(v)1.5 channels at arginine, resulted in cardiac arrhythmias."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23661717,"The slowly conducting embryonic phenotype is maintained in fetal and adult right ventricular outflow tract and is unmasked when SCN5A function is reduced."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23656992,"When human macrophage NaV1.5 splice variant is expressed in vivo in mouse macrophages, mice are protected from experimental autoimmune encephalomyelitis."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23631430,"Mutations in SCN5A were associated with a higher frequency of cardiac arrest (52.6) in patients with long QT syndrome."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23612926,"Brugada-like ST elevation in the inferior ECG leads or isolated conduction disturbances were found in two unrelated families and associated with two novel SCN5A mutations."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23571586,"5 intrauterine fetal deaths hosted SCN5A rare nonsynonymous genetic variants that conferred in vitro electrophysiological characteristics consistent with potentially proarrhythmic phenotypes."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23558814,"A new, previously unknown, mutation of the SCN5A gene has been found in the family of a malignant course long QT syndrome."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23541953,"Cav3 is an important negative regulator for cardiac late sodium cutrrent via nNOS dependent direct S-nitrosylation of SCN5A."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23538271,"This observation confirms the possibility that SCN5A mutations may confer susceptibility for recurrent seizure activity, supporting the emerging concept of a genetically determined cardiocerebral channelopathy."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23503384,"Phenotype-genotype correlation was studied in SCN5A-positive and SCN5A-negative patients. Rare genetic variants in SCN5A gene were found in 7 of 21 Russian probands (28%)."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23465283,"A very high prevalence of previously SIDS-associated variants was identified in exome data from population studies."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23424222,"Na(V)1.5-S1218I and R811H are novel loss-of-function mutations in the SCN5A gene causing Brugada syndrome."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23414114,"High prevalence of CACNA2D1, SCN5A, and CACNB2 genetic variants in the Danish population previously associated with Brugada syndrome has been found in new exome data."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23376825,"Novel mutations in SCN5A and SNTA1 jointly increase the INa current late/peak ratio and time constants of current decay."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23359282,"Our results advance our understanding about the mechanism of Na(V)1.9 potentiation by G-protein signaling during inflammation."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23321620,"Brugada syndrome SCN5A gene mutation carriers have a significantly increased risk of major arrhythmic events."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23308164,"The study shows evidence of loss-of-function of the mutant Nav1.5 channel, which is consistent with the patient's clinical manifestation of Brugada syndrome."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23283979,"Cys-373 and His-880 in Na(V)1.5 are proton sensors for use-dependent and slow inactivation and have implications in isoform-specific modulation of Na(V) channels"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23277474,"Our studies demonstrate a primary LQT-3 (Na+ channel) defect not influenced by the KCNH2 polymorphism and drug interactions unique to the proband that correlate with improved management of arrhythmias in the patient."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23257389,"The Val110Ile mutation of SCN3B is a relatively common cause of SCN5A-negative BrS in Japan, which has a reduced sodium current because of the loss of cell surface expression of Nav1.5."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23237912,"SCN5A gene mutation and abnormality is associated with long Qt syndrome development."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23200271,"Two novel mutations in SCN5A were associated with pediatric sick sinus syndrome."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23168001,"[review] A novel missense mutation is identified that is linked to ventricular fibrillation, early repolarization and conceealed myocardial abnormalities."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23133651,"The beta1-subunit of Na(v)1.5 cardiac sodium channel is required for a dominant negative effect through alpha-alpha interaction"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23123192,"Several pools of NaV1.5 channels may co-exist in cardiac cells. (Review)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23036686,"expression of the sodium (SCN5A) and potassium (KCND3) channels as well as the fibrosis content in the ventricles of heart failure and of non-diseased hearts under different post-mortem intervals"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,23008441,"Two human arrhythmia variants affect Nav1.5 channel activity through posttranslational modification."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22999724,"The R222Q SCN5A variant has an activating effect on sodium channel function and is associated with reversible ventricular ectopy and dilated cardiomyopathy."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22984773,"Data indicate that 10.5% of patients had mutations in the SCN5A gene."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22980924,"A novel deletion mutation was identified in SCN5A linked to long QT syndrome."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22952230,"Each set of six transmembrane regions in Nav1.5 likely constitutes a Sig1R binding site, suggesting that the Sig1R interacts with the transmembrane regions of its binding partners."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22951351,"Nav1.5 contributes to the phagocytic pathway of myelin degradation in macrophages in vivo within multiple sclerosis lesions."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22899775,"Estimated heritability for isolated conduction disturbances was 91% (95% confidence interval, 80%-100%); SCN5A mutation screening identified 2 mutations in 2 patients among 97 children."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22882672,"Report prevalence of SCN5A mutations in cohort of young sudden unexplained death cases."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22876298,"Loss-of-function SCN5A mutations are associated with dilatation and impairment in contractile function of both ventricles that can be detected by CMR analysis."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22842345,"SCN5A-SCN4B were found to be essential for positive selection of CD4(+) T cells."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22826127,"The human Nav1.5 F1486 deletion associated with long QT syndrome leads to impaired sodium channel inactivation and reduced lidocaine sensitivity"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22802584,"Using the patch clamp technique we show that atrial myofibroblasts display a fast inward voltage gated sodium current with a density of 13.28 +/- 2.88 pA pF(-1) whereas no current was detectable in non-differentiated fibroblasts."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22795782,"Mutational screening of the SCN5A gene showed that this case was a compound heterozygote for p.Ala735Val and p.Asp1792Asn missense mutants."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22766342,"A new SCN5A-related cardiac syndrome, multifocal ectopic Purkinje-related premature contraction (MEPPC) was identified.  The SCN5A mutation leads to a gain of function of the sodium channel responsible for excitability of the fascicular-Purkinje system."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22739120,"R104W, R121W, and DeltaNter mutations abolished the sodium current I(Na) in HEK293 cells."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22722661,"SkM1 biophysical properties in mesenchymal stem cells are more favorable than SCN5A in restoring fast conduction in depolarized tissue."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22721569,"SCN5A V411 M mutation leads to a hyperactive sodium channel, apparently due to an increase in the probability of aperture of the mutated channel"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22710484,"A mutation in the voltage sensor of cardiac sodium channels can cause bigeminal arrhythmia associated with cardiomyopathy."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22685113,"A high prevalence of SCN5A mutations previously associated with long QT syndrome type 3, were identified."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22682427,"Autopsy of a 30 year old Japanese male who died of sudden unexpected nocturnal death syndrome attributed cause of death to a heterozygous mutation causing an R1193Q amino acid substitution in the SCN5A gene"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22633666,"Our study demonstrates the functional consequence of a 5' splice site of SCN5A responsible for Brugada syndrome."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22562703,"Murine Scn5a locus was disrupted, and expression of human wild-type SCN5A cDNA substituted, identifying variable late I(Na) as a modulator of gender-dependent arrhythmia susceptibility."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22560601,"epinephrine injection helps to distinguish silent LQTS mutation SCN5A carriers. This concerns also the LQT3 subtype"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22514276,"CaMKII-dependent phosphorylation of Na(V)1.5 at multiple sites (including Thr-594 and Ser-516) appears to be required to evoke loss-of-function changes in gating that could contribute to acquired Brugada syndrome-like effects in heart failure."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22486578,"Electrophysiological findings indicate increased atrial arrhythmogenicity with maximal effects on both conduction and repolarization characteristics in young compared with aged transgenic Scn5a+/- mice."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22461438,"Scn5a+/- hearts from transgenic mice show greater frequencies of arrhythmic endpoints with increased incidence of ventricular tachycardia compared to wild type."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22460359,"A review focusing primarily on recent findings of Nav1.5 mutations associated with type 3 long QT syndrome."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22426227,"map of the location of the functionally critical distal C-T (carboxy terminus) helix (H6) relative to the proximal C-T and demonstrate interactions between H6 and the EF-hand motif in the contiguous C-T; constructed a model of the predicted structured region of the carboxy terminus"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22400069,"Finding sugget that Foxo1 regulates Na(V)1.5 expression by directly binding the SCN5a promoter and affecting its transcriptional activity."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22370247,"specific promoter variants increase the risk of severe cardiac events in heterozygous carriers of an SCN5A loss-of-function mutation"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22331908,"The 1.35 A structure of Ca(2+)-bound calmodulin in complex with the DIII-IV linker of Na(V)1.5 suggests that Ca(2+)/CaM destabilizes binding of the inactivation gate to its receptor, biasing inactivation toward more depolarized potentials."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22277643,"Carriers had, on average, longer P-wave duration, PR, and QRS intervals and higher transmural dispersion of repolarization for Brugada syndrome."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22117993,"this study provided evidence for the role of the H558R polymorphism of the SCN5A gene in increasing the susceptibility to atrial fibrillation"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22101522,"The activation of protein kinases can acutely regulate the intracellular distribution and molecular mobility of cardiac Na(+) channels in living cells."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22092558,"These results suggest that NaV1.5 and mitochondrial-dependent calcium signaling regulate mycobacteria phagocytosis and phagosome maturation in human macrophages."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22090166,"Genetic testing reveals disease-causing mutations in depolarizing sodium (SCN5A) or calcium (CaCNB2b) channels in 5 infants with rapid ventricular tachycardia, conduction abnormalities, and Brugada-like syndrome."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22067152,"The expression human variant of Na(V)1.5 with and without the modulating beta(1) subunit in Xenopus oocytes and Lowering extracellular pH from 7.4 to 6.0 affected a range of biophysical gating properties heretofore unreported."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22064211,"The researchers report on a case of early onset arrhythmia in fetal long qt syndrome that may be associated with a SCN5A mutation."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,22028457,"Found reductions in heart rate and cardiac conduction and loss-of-function mutations in SCN5A in patients with idiopathic ventricular fibrillation associated with early repolarization."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,21996251,"hERG and hNa(V)1.5 screens run using frozen cells have statistically identical IC(50)s."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,21937582,"Molecular determinants of normal Na(v)1.5 expression and function. Review."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,21859973,"RBM25/LUC7L3-mediated abnormal SCN5A mRNA splicing reduced Na+ channel current 91.1+/-9.3% to a range known to cause sudden death."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,21840964,"The small peptides, spanning the H558R polymorphism, are sufficient to restore the trafficking defect of BrS-associated Na(v)1.5 mutations."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,21824921,"Despite producing near-normal currents in heterologous expression experiments, the D1275N SCN5A mutation is a pathological mutation that generates conduction slowing, arrhythmias, and dilated cardiomyopathy by reducing cardiac sodium current."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,21705349,"Expression of S216L SCN5A was associated with a 60% reduction in maximum Na(+) current (I(Na)) density, attributable to protein misfolding (rescued by mexiletine pretreatment) and moderate slowing of inactivation"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,21609529,"Readthrough-enhancing reagents could effectively suppress nonsense mutations in SCN5A and partially restore the function of sodium channel and the expression of full-length channels."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,21596231,"SCN5A mutation showed strong correlation to arrhythmic dilated cardiomyopathy."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,21552533,"electrophysiological properties of mutant T1620K channels in the background of all known functional Na(v)1.5 splice variants in HEK293 cells"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,21498565,"S1103Y variant in SCN5A is associated with a higher incidence of ventricular arrhythmias in blacks with heart failure and reduced ejection fraction."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,21454796,"Variations in the gene encoding for the major sodium channel (Na(v)1.5) in the heart, SCN5A, has been shown to cause a number of arrhythmia syndromes."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,21397042,"family with significant Brugada syndrome and a novel mutation in exon 23 of the SCN5A gene.This mutation may have substantial impact on the function of the cardiac sodium channel."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,21393430,"H(2)S activates the gastrointestinal Na(+) channel, Nav1.5, and the mechanism of action of H(2)S is partially redox independent."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,21385947,"The common African American polymorphism SCN5A-S1103Y interacts with mutation SCN5A-R680H to increase late Na current"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,21325150,"SCN5A SNPs are all located in the 3' region of the gene and associated with multiple ECG traits."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,21321465,"study analyzed the SCN5A gene to elucidate the potential variability of clinical features in Japanese Brugada syndrome subjects; identified 8 different SCN5A mutations, including 6 novel mutations"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,21288276,"A large-scale rearrangement of the SCN5A gene in Brugada syndrome supports an association between molecular pathology and phenotypic expression."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,21273195,"In Brugada syndrome, the presence of an SCN5A mutation is associated with intra-atrial conduction slowing and suppressed atrial ectopic activity. Intra-atrial conduction slowing may provide a plausible substrate for atrial fibrillation maintenance."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,21185499,"CNVs involving SCN5A seems to be extremely rare in LQTS."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,21170089,"Na(V)1.5 and NHE1 are functionally coupled and enhance the invasiveness of cancer cells by increasing H(+) efflux."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,21167176,"The Na(V)1.5 IQ motif interacts with the C-terminal domain (C-lobe) of calmodulin, with the N-terminal domain remaining free. The structure shows that the C-lobe adopts a semi-open conformation with the IQ motif bound in a narrow hydrophobic groove."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,21167004,"The biophysical findings, dependent upon common SCN5A variants, provide further evidence that these novel SCN5A rare variants are relevant for dilated cardiomyopathy."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,21164104,"SAP97 and dystrophin macromolecular complexes determine two pools of cardiac sodium channels Nav1.5 in cardiomyocytes."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,21126620,"Familial forms of BrS were observed in 41 of the 62 families (66%) and no SCN5A mutations were found in sporadic forms."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,21109022,"The SCN5A-H558R polymorphism might play an important role in stabilization of channel fast inactivation and may be a disease-modifying gene."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,21076026,"Y1767C, a novel SCN5A mutation, induced a persistent Na+ current and potentiated ranolazine inhibition of Nav1.5 channels."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,21070882,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,21063070,"Observational study of genetic testing. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,21048329,"SCN5A mutations are associated with early and frequent VF recurrence, but not with initial VF episodes. This is the first report on the genotype-phenotype interaction and clinical significance of this mutation."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,21048329,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20920651,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20875080,"KCNH2 Arg176Trp and SCN5A Pro1090Leu were identified once in Sudden unexpected death in epilepsy cases and absent in control alleles"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20875080,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20812931,"We describe a family harboring 2 SCN5A mutations: the DeltaKPQ mutation, the \"classical\" gain-of-function mutation associated with Long-QT syndrome, and the I1660V mutation, a loss-of-function mutation associated with Brugada syndrome."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20724705,"Altering the oxidized to reduced NAD(H) balance can activate mitochondrial reactive oxygen species production, leading to reduced I(Na) via SCN5A"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20651255,"Data established a role of SCN5A as a regulator of a colon cancer invasion network, involving genes that encompass Wnt signaling, cell migration, ectoderm development, response to biotic stimulus, steroid metabolic process, and cell cycle control."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20628086,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20618077,"Alternative promoter usage and splicing of the human SCN5A gene contribute to transcript heterogeneity."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20609320,"genetic analysis could be helpful in the presymptomatic diagnosis of Brugada syndrome, but may be less useful for stratifying the risk of adverse events"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20586826,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20539757,"study indicates that multiple molecular mechanisms, including gating abnormalities, trafficking defects, or a combination of both, are responsible for SCN5A-related familial sick sinus syndrome"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20470418,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20403459,"There is sufficient evidence to conclude that A572D-SCN5A is not an independent LQT3-causative mutation.  Epidemiologic, molecular and functional evidence suggests that A572D is functionally aberrant but nonpathogenic."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20403459,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20400777,"Two common intronic variants in KCNQ1 and SCN5A were associated with sudden cardiac death in individuals of European ancestry."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20400777,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20395683,"novel SCN5A mutation (R121W) afflicted by sick sinus syndrome, progressive cardiac conduction disorder, atrial flutter and ventricular tachycardia"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20386770,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20384651,"We conclude that polymorphism H558R has mutation-specific effects on SCN5A-related sick sinus syndrome"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20379614,"Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20372843,"Abnormal expression of Nav1.5 could be an integral component of the metastatic process in human ovarian cancer."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20339117,"The sodium channel blocker mexiletine may facilitate trafficking of mutant SCN5A proteins, thus exacerbating QT prolongation."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20219395,"Oxidative stress is elevated in the myocardium of patients with Brugada-type electrocardiogram who have ventricular fibrillation episodes and do not have SCN5A gene mutations."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20201937,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20174578,"Studies indicate that Scn5a(+/-) mice show similar phenotypic heterogeneity as SCN5A-mutated patients."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20147455,"Our observations suggest that the upregulated expression of Nav1.5 in astrocytes may provide a compensatory mechanism, which supports sodium/potassium pump-dependent ionic homoeostasis in areas of central nervous system injury."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20129283,"In this case-control study, the researchers found that 21% of Brugada Syndrome probands had SCN5A mutations compared to only 2% to 5% in a control group."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20116193,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20110800,"This is the first report of an epidemiological survey and SCN5A gene screening in sudden unexplained nocturnal death syndrome (SUNDS) in the Han population of China."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20110800,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20108749,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20102920,"Increased risk cardiac events and mortality associated with long QT syndrome type 3 with deletional vs missense mutations of SCN5A."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20090423,"If stretch-modulated Na(V)1.5 current routinely contributes to cardiac mechanoelectric feedback, then during hemodynamic load variations, the abnormal stretch-modulated components of R1623Q and R1626P current could be pro-arrhythmic."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20062060,"Meta-analysis and genome-wide association study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20038812,"study showed that a paroxysmal extreme pain disorder mutation in the Nav1.7 channel, a paramyotonia congenita mutation in the Nav1.4 channel & a long-QT3/SIDS mutation in the NAV1.5 channel all increased the amplitude of resurgent sodium currents"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20031634,"SCN5A mutations are not direct cause of Brugada syndrome."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20025708,"A novel SCN5A mutation, P1008S, was identified in all family members displaying first-degree atrioventricular block, but not in unaffected family members nor in 430 reference alleles."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20009079,"Alpha1-syntrophin mutations identified in sudden infant death syndrome cause an increase in late cardiac sodium current."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,20004937,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19948241,"Activity-dependent positive feedback mediated by protein kinase a plays an important role in the functional expression of nNav1.5 in breast cancer."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19913121,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19861310,"Enhanced tubulin polymerization reduces sarcolemmal Na(v)1.5 expression and I(Na) amplitude in a beta1-subunit-independent fashion and causes I(Na) fast and slow inactivation impairment in a beta1-subunit-dependent way"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19845816,"the functional role of Nav1.5 in propagation and depolarization both in a normal- and in a pathophysiological setting (Review)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19843921,"Exercise aggravated the ECG phenotype in BrS. The presence of an SCN5A mutation was associated with further conduction slowing at fast heart rates."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19843919,"In dLQTS subjects, 1 SCN5A heterozygous missense mutation was identified."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19841300,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19822451,"Our results suggest that the transcription of the SCN5A Dip.D variant may be associated with arrhythmogenic diseases that can induce sudden death."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19822451,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19808664,"Results demonstrate that calcium-dependent calmodulin binding to the sodium channel inactivation gate double tyrosine motif is required for calcium regulation of the cardiac sodium channel."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19808432,"Case Report: Demonstrate molecular basis for malignant perinatal presentation of long-QT syndrome, illustrate novel SCN5A-G1631D, which caused the disorder, and reveal benefits of propranolol block of mutant sodium channels."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19808398,"A1180V expresses mild Na(+) channel phenotype in vitro and clinical phenotype in unaffected mutation carriers, implying that A1180V caused structural heart disease in affected carriers by disturbing Na(+) influx and cellular Na(+) homeostasis."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19745168,"Mutations of GPD1-L may downregulate Na(v)1.5 by altering the oxidized to reduced NAD(H) balance."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19719504,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19716085,"The researchers found evidence of SCN5A mutations in a cohort of patients with long QT syndrome."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19716085,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19706159,"The A551T mutation reduced Nav1.5 activity by promoting channel entry into fast inactivation from the closed state, shifting the steady-state inactivation curve by -5 mV. The DI-DII linker may be involved in inactivation-gating-process stability."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19698999,"The properties of the voltage-gated Na+ current found in a microglial cell line derived from the human central nervous system suggests that this current is predominantly mediated by the cardiac sodium channel Na(v)1.5."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19666841,"GPD1L links redox state to cardiac excitability by PKC-dependent phosphorylation of the sodium channel SCN5A."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19661462,"Reprot the use of lidocaine and benzocaine to link SCN5A channel molecular conformations to state-dependent antiarrhythmic drug affinity."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19632628,"The investigators evaluated the relationship between SCN5A mutations, Brugada syndrome, and ventricular fibrillation and found evidence of loss of rate-dependent QT dynamics in cases of ventricular fibrillation in Brugada syndrome."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19551538,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19549036,"The common variant H558R seems to be a genetic modulator of Brugada syndrome among carriers of a SCN5A mutation, in whom the presence of the less common allele G improves the ECG characteristics and clinical phenotype."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19549036,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19419784,"A mutation between the III and IV domains of Na(v)1.5 is associated with fatal long QT syndrome in a newborn infant."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19412328,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19406494,"Novel mutations in SCN5A are a frequent underlying cause of Brugada syndrome in patients of Greek origin."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19389651,"The PR interval and its subcomponents showed substantial heritability in a South Pacific islander population and were associated with common genetic variation in SCN5A."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19389651,"Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19377070,"Readthrough of nonsense mutation W822X in the SCN5A gene can effectively restore expression of cardiac Na+ channels."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19376164,"These results suggest that Nav1.5 channels in human and rat brains are encoded by new variants of Nav1.5/SCN5A and Nav1.5 is more widely distributed and expressed than previously thought."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19345130,"We describe the first sodium channel mutation to be associated with the development of an arrhythmic storm during acute ischemia. These findings suggest that a loss of function in SCN5A may predispose to ischemia induced arrhythmic storm."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19340536,"The auxiliary beta(1) subunit modulates I(NaL), produced by the human cardiac Na(+) channel Na(v)1.5 by slowing its decay and increasing I(NaL) amplitude relative to I(NaT)."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19324308,"Patients without SCN5A mutation often had PVCs of LBBB, inferior-axis morphology, suggesting a right ventricular outflow tract origin. Patients with SCN5A mutations had PVCs that originated from both the right and left ventricles."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19324308,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19322600,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19318916,"the anaphylactic reaction that occurred in the young man could serve as a trigger mechanism, responsible for his sudden death with a SCN5A mutation associated with the Brugada syndrome."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19305639,"Atrial fibrillatory rate obtained from the surface ECG is not determined by SCN5A genotype."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19305639,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19305409,"Genome-wide association study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19305408,"Meta-analysis and genome-wide association study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19302788,"sudden infant death syndrome was secondary to the long QT syndrome type 3-associated S1333Y mutation of SCN5A"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19279232,"Na(+) channels represent a new addition to the large number of voltage-gated ion channels modulated by sigma-receptors"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19272188,"Results report three novel SCN5A mutations identified in patients with Brugada syndrome in Taiwan."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19255801,"Anti-Nav1.5 antibody selectivity was demonstrated in transfected HEK293 cells."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19251209,"in loss-of-function SCN5A channelopathies patients carrying T and M(inactive) mutations develop a more severe phenotype than those with M(active) mutations"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19251209,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19224165,"Nav1.5 functional expression potentiated the invasive behavior of human breast cancer cell line MDA-MB-231 by increasing the secretion of MMP-9."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19171938,"mutation of the IQ domain (A1924T; Brugada Syndrome) that reduces CaM binding stabilizes Na(V)1.5 inactivation, similarly and more extensively than even reducing [Ca(2+)](i)."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19167345,"A novel SCN5A coding variant, K1493R, located six amino acids downstream from the fast inactivation motif of sodium channels was idetified in atrial fibrillation."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19149796,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19121811,"The functional characteristics and the electrophysiological consequences of the mutations did not enter into the decision \"ICD versus other therapies without ICD,\" and a SCN5A mutation was sufficient to dictate ICD implant."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19083750,"sequence variations in the 3' untranslated region (3'UTR) and 5' untranslated region (5'UTR) of the SCN5A gene were observed in sudden unexplained death"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19075524,"novel nonsense mutation (R179X) of SCN5A in ventricular fibrillation in Brugada syndrome"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19074138,"Solution NMR structure of the C-terminal EF-hand domain of human cardiac sodium channel NaV1.5"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19056759,"G298S-SCN5A missense mutation caused a marked reduction of whole cell Na(+) current and loss of function of Na(v)1.5, suggesting SCN5A as a candidate gene in the pathophysiology of irritable bowel syndrome."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19056759,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19027780,"Outlines the currently known SCN5A mutations linked to three distinct cardiac rhythm disorders: long QT syndrome subtype 3 (LQT3), Brugada syndrome (BS), and cardiac conduction disease (CCD). Review."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,19026623,"Observational study of genetic testing. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18977767,"Expression of skeletal SkM1 but not cardiac SCN5A Na+ channel isoform preserves normal conduction in a depolarized cardiac syncytium."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18929331,"This is the first report showing an association of familial AF and LQT-3 due to a mutation in SCN5A"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18929244,"SCN5A mutation causes a familial form of atrial fibrillation without any underlying structural heart disease."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18848812,"SCN5A/R43Q variant, although it per se does not prolong repolarization, contributes to the development of ventricular tachyarrhythmias after lidocaine."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18803136,"In post-MI patients two exonic polymorphisms, H558R in SCN5A and S38G in KCNE1, were detected. H558R was associated with an increase in QT dispersion at minimum and maximum heart rate and QT interval prolongation before premature ventricular beats."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18803136,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18752142,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18708744,"A novel LQT-3 mutation in SCN5A disrupts an inactivation gate complex with distinct rate-dependent phenotypic consequences."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18690024,"Report the irreversible block of cardiac mutant Nav1.5 channels by batrachotoxin."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18676988,"Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18674739,"The effect of 3 ion channel gene single nucleotide polymorphisms (SNPs), rs1805127, rs727957 KCNE1, and rs1805124 SCN5A, on T-wave alternans during a clinical exercise test, was examined."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18674739,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18657562,"The independence of the effects of ProTxII on activation and inactivation of sodium channels is reported."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18616619,"Clinical consequences of the novel R878C mutation; correlation with the results of physiological studies"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18596570,"Report cardiac SCN5A gene mutations in sudden infant death syndrome."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18596570,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18591664,"These results establish an SNTA1-based nNOS complex attached to SCN5A as a key regulator of sodium current and suggest that SNTA1 be considered a rare long QT syndrome-susceptibility gene."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18503232,"It is unlikely that an intragenic interaction between R1232W and T1620M of SCN5A causes a trafficking defect leading to a non-functioning Na channel"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18456723,"In Brugada syndroms subepicardial phase 0 block and discontinuous transmural conduction underlie right precordial ST-segment elevation by a SCN5A loss-of-function mutation."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18452875,"This study provides an independent assessment of the prevalence of S1103Y-SCN5A among African-American infants with sudden, unexpected, unexplained death prior to their first birthday"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18452875,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18452871,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18451998,"the E1784K mutation in SCN5A may have a role in mixed clinical phenotype of type 3 long QT syndrome"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18436145,"overview of current knowledge on SCN5A mutations associated with sodium channel overlap syndromes [review]"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18426444,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18408010,"telethonin is a sodium channel-interacting protein, and its mutations can alter Na(v)1.5 kinetics and may play a role in intestinal pseudo-obstruction"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18393272,"Results provide an electrophysiological comparison of 'neonatal' and 'adult' isoforms of Nav1.5, and describe the critical involvement of a lysine residue."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18378609,"8 new variants affecting higly conserved residues were identified. The new variants cosegregated with AF.  11 rare missense variants were also seen. Mutations or rare variants in SCN5A may predispose patients w/wo underlying heart disease to AF."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18378609,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18368697,"The left ventricular noncompaction patients with heart failure also had high occurrence of SCN5A variants, suggesting the presence of SCN5A variants and/or arrhythmias increase the severity of LVNC."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18368697,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18362431,"The 87A allele might be associated with an increased risk of idiopathic ventricular arrhythmia in females, whereas 1673G allele might have been positively selected because of its protective effects against ventricular arrhythmia in males."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18362431,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18355654,"SCN5A, a gene encoding the cardiac sodium channel, has been reported to be causally related to BrS"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18355654,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18252757,"Mutations of the C-terminal domain of SCN5A alter the inactivation of the channel and support the notion that conduction alterations may play a significant role in the pathogenesis of Brugada syndrome."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18245395,"SCN5A R1193Q polymorphism associated with progressive cardiac conduction defects and long QT syndrome in a Chinese family."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18184654,"in cardiomyocytes, MOG1 is mostly localized in the cell membrane and co-localized with Nav1.5, indicating that MOG1 is a critical regulator of sodium channel function in the heart"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18156160,"reports the case of a family in which the occurrence of Brugada syndrome and isolated cardiac conduction disease could be due to the P1438L SCN5A mutation, but also to the accidental association of both diseases."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18088563,"The researchers found a single SCN5A mutation association with arrhythmia in a familial cohort with atrial fibrillation, which suggests this variation in the SCN5A gene is not a significant cause of familial atrial fibrillation"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18071069,"Functionally significant mutations and rare variants in SCN5A may contribute to sudden cardiac death risk among women"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18065446,"Describe combination of cardiac conduction disease and long QT syndrome caused by mutation T1620K in the cardiac SCN5A sodium channel."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18048769,"the divergent biophysical defects caused by 2 different SCN5A mutations associated with familial dilated cardiomyopathy."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,18040022,"REVIEW of role of SCN5a mrna levels and mrna genetic variation in congestive heart failure"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,17967977,"A GPD1-L mutation decreases SCN5A surface membrane expression, reduces inward Na+ current, and causes Brugada syndrome"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,17928536,"V930 in D2-S6 appears to be an important structural determinant of slow inactivation gating."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,17905336,"Observational study of genotype prevalence. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,17901361,"chronic HF was associated with an increase in 2 truncated SCN5A variants and a decrease in the native mRNA"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,17897635,"The SCN5A mutation has a marked loss-of-function and unique phenotype of sick sinus syndrome, cardiac conduction disorder and ventricular tachycardia with incomplete penetrance."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,17854786,"The DIIIS4-S5 linker is a new region involved in slow inactivation of Na(v)1.5. The biophysical alterations of the G1319V mutation all contribute to a reduction in I(Na), in line with the proposed mechanism underlying Brugada syndrome."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,17697823,"conduction slowing was more marked and more progressively accentuated in Brugada probands with SCN5A mutation than in those without SCN5A mutation."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,17675083,"Results suggest that a subclinical mutation in SCN5A resulting in a loss of function may predispose to life-threatening arrhythmias during acute ischemia."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,17605181,"mutations in SCN5A gene, which codes the alpha-subunit of the sodium channel Na(v)1.5 makes it possible to more fully consider possible ways of the development of cardiac rhythm disorders and use the most optimal methods for their treatment."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,17556197,"Observational study of genotype prevalence. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,17556197,"Finds evidence that large genomic rearrangements in SCN5A are not associated with Brugada syndrome."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,17548620,"We demonstrate that the cardiac voltage-gated sodium channel, NaV1.5, is expressed on the late endosome in human monocyte-derived macrophages."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,17544529,"In Australians <35 years with a negative autopsy at sudden death, nine DNA sequence variants were identified int he SCN5A gene."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,17544529,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,17534376,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,17510181,"The positions of the S4s in domains III and IV of SCN5A are major determinants of the voltage dependence of lidocaine affinity."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,17496023,"Human heart Nav1.5 pore alpha-subunit in xenopus oocytes measure small macroscopic currents in cell-attached patches."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,17363383,"Electrostatic repulsion is critical component of the mechanism of local anesthetic block of the SCN5A sodium channel."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,17331104,"A common SCN5A polymorphism, S524Y, can enhance a use-dependent block by class Ia and Ic antiarrhythmic agents."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,17275752,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,17227473,"Study confirms that some Brugada syndrome patients without exonic mutations in SCN5A had no other SCN5A abnormalities, including any involving the location of the SCN5A protein."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,17210841,"Our present results greatly expand the spectrum of functionally characterized SCN5A variants associated with sudden infant death syndrome and provide further biophysical correlates of arrhythmia susceptibility in this syndrome."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,17210839,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,17210839,"We demonstrated that 9.5% of cases diagnosed as SIDS carry functionally significant genetic variants in LQTS genes (KCNQ1, KCNH2, SCN5A, KCNE1, KCNE2, KCNJ2, CAV3)."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,17205354,"Residue hNav1.5-S401 at D1S6 is facing the inner cavity and is in close proximity to the receptor sites for batrachotoxin and for local anesthetics."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,17198989,"a novel threonine-to-isoleucine missense mutation at position 353 (T353I) adjacent to the pore-lining region of domain I of the cardiac sodium channel (SCN5A) in a family with Brugada syndrome"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,17185997,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,17161064,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,17161064,"Six novel mutations--4 in ANK2, 1 in KCNQ1, and 1 in SCN5A--were found in the patients with torsades de pointes."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,17141278,"The SCN5A (W1191X) mutation is associated with Brugada syndrome and resulted in the loss of function of the cardiac sodium channel."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,17075016,"Compound heterozygous mutations Pro336Leu and Ile1660Val of SCN5A modulate the phenotypic expression and penetrance of Brugada syndrome."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,17070808,"local anesthetic's (LA) cationic group and a Na+ ion in the selectivity filter repel each other suggesting that the Na+ depletion upon slow inactivation would stabilize a LA, while a LA would stabilize slow-inactivated states"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,16980337,"The AP abnormalities induced by Y1795H and Y1795C can explain the clinically observed surface ECG phenotype."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,16930557,"The protein tyrosine phosphatase PTPH1 binds to the PDZ-domain binding motif of the cardiac voltage-gated sodium channel Na(v)1 and regulates the activity of Na(v)1."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,16880338,"Persons who inherit polymorphisms of the SCN5A gene have a loss of function mutation of the gene and more severe forms of Brugada syndrome."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,16877553,"The findings also suggest how Brugada syndrome and PCCD which both result from loss of sodium channel function are sometimes present alone and at other times in combination."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,16873405,"We demonstrate that a pH-independent current is found in Na(V)1.4, but not in the cardiac isoform (Na(V)1.5)."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,16864729,"The R282H-SCN5A mutation in the sodium channel gene was identified in patients with Brugada syndrome."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,16857961,"Dystrophin protein complex is required for the proper expression and function of Na(v)1.5 in mice."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,16847056,"Data show that the varied effects of beta1 and beta2 on Nav1.5 and Nav1.2 gating are apparently synergistic and highlight the complex manner, through subunit- and sugar-dependent mechanisms, by which Nav activity is modulated."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,16818214,"Observational study of genetic testing. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,16771953,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,16731473,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,16728661,"14-3-3 protein is a novel component of the cardiac Na(v)1.5 channel acting as a cofactor for the regulation of the cardiac sodium ion current."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,16674915,"We propose that D2-S6 in hNav1.5 undergoes molecular rearrangement during slow inactivation exposing the side chain of residue 930 such that it becomes accessible to modification by MTSEA."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,16643374,"Human genetic studies have identified mutations in the sodium channel SCN5A gene causing tachyarrhythmia disorders, as well as progressive cardiac conduction system diseases, or overlapping syndromes."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,16632547,"These data show that a trafficking defect (SCN5A mutation) may be partial and time dependent and may differ with the splice variant background. Expression defects and gating abnormalities may contribute to loss of function for the same mutation."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,16505387,"comprehensive model is proposed in which the hH1 IQ motif serves as a molecular switch, coupling the intrinsic and extrinsic calcium sensors"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,16469732,"describes a novel splice variant of Na1.5 that could be detected in all human heart RNA samples investigated; characterized by altered Na+ current amplitude and gating"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,16453024,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,16453024,"data show that mutant SCN5A channels operate normally under baseline conditions in vitro but abnormally under reduced pH conditions; findings suggest that infants with 2 copies of S1103Y have a 24-fold increased risk for sudden infant death syndrome"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,16426410,"Mutations in the SCN5A gene can cause Brugada syndrome, a genetically inherited form of idiopathic ventricular fibrillation."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,16415376,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,16415376,"genetically determined variable sodium channel transcription occurs in the human heart and is associated with variable conduction velocity, an important contributor to arrhythmia susceptibility"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,16414944,"Observational study of genotype prevalence and genetic testing. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,16344400,"Mutations in the SCN5A gene, identified in 4 of the 18 patients with Brugada syndrome, may have induced concealed structural abnormalities of myocardiocytes that accounted for paroxysmal arrhythmic manifestations."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,16325048,"Brugada plus bradyarrhythmias type of overlap syndrome was caused by single SCN5A mutations that result in a complete loss-of-function in cardiac Na channels."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,16301357,"new mechanism in the drug-induced long-QT syndrome also strongly supports the concept that variable cell surface expression contributes to clinical variability in the LQT3 phenotype"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,16254012,"dynamic action potential clamp data directly demonstrate the arrhythmogenic nature of LQT3-associated SCN5A mutations"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,16207794,"Data demonstrate that the double mutations at the 409 and 410 sites in cardiac Na(+) channels induce inactivation-deficient sodium currents (INa) and that n-3 polyunsaturated fatty acids inhibit mutant I(Na)."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,16188595,"Genetic defects in SCN5A most likely underlie atrial standstill."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,16132053,"Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,16132053,"This suggests that genetic determinants located in KCNQ1, KCNE1, KCNH2 and SCN5A influence QTc length in healthy individuals and may represent risk factors for arrhythmias or cardiac sudden death in patients with cardiovascular diseases."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,16115203,"These results suggest that SCN5A has a newly identified exon for alternative splicing and is more widely expressed than previously thought."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,16061851,"Up-regulation of neonatal Na(v)1.5 occurs as an integral part of the metastatic process in human breast cancer"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,16061744,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,16061744,"The Y1102 allele is a risk factor in blacks for sudden cardiac death in the absence of obvious morphological findings or mild to moderate cardiomegaly."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,15996170,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,15910881,"a human cardiac sodium channel mutation(E161K) may have a role in sick sinus syndrome, conduction disease and Brugada syndrome"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,15863661,"Observational study of genotype prevalence. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,15851320,"Observational study of genotype prevalence. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,15851227,"Observational study of genotype prevalence. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,15851119,"Observational study of genotype prevalence. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,15840476,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,15828879,"Brugada syndrome is an inherited cardiac disorder caused by mutations in the SCN5A gene encoding the cardiac sodium channel alpha-subunit, and potentially leads to ventricular fibrillation and sudden death."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,15808832,"A novel intronic mutation in the SCN5A gene in a large family with Brugada syndrome was identified."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,15805167,"mechanisms for S1759 involvement in slow inactivation and for antagonism between fast and slow inactivation"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,15746172,"Chimeric channels of NaV1.4 and NaV1.5 also indicated that the C-terminal domain is largely responsible for calmodulin effects on inactivation"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,15671429,"Heritable SCN5A defects are associated with susceptibility to early-onset DCM and atrial fibrillation. Similar or even identical mutations may lead to heart failure, arrhythmia, or both."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,15665061,"Phenylalanine deletion alters the voltage dependence of fast inactivation via a reduction in the gating charge."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,15579534,"ankyrin-G participates in a common pathway for localization of voltage-gated Na(v) channels at sites of function in multiple excitable cell types"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,15534720,"Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,15504354,"Acute and chronic cell hypoxia regulate sodium currents by recombinant hNa(v)1.5 alpha."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,15466643,"A heterozygous G-to-A mutation at position 3823(D1275N) in a highly conserved residue of exon 21 is associated with an autosomal dominant cardiac conduction disorder, sinus node dysfunction, arrhythmia, ventricular dilatation & dysfunction."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,15367556,"Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,15338453,"Observational study of genotype prevalence. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,15338453,"report of a novel mutation in SCN5A associated with Brugada syndrome in Koreans"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,15316014,"Calmodulin mediates Ca2+ sensitivity of Nav1.2 and Nav1.5 sodium channels"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,15306732,"SCN5A gene is not commonly involved in the pathogenesis of the Brugada Syndrome and associated disorders."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,15277732,"Two novel SCN5A mutations have been found in Japanese patients with Brugada syndrome."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,15217910,"Na(v)1.5 can be ubiquitinated in heart tissues and that the ubiquitin-protein ligase Nedd4-2 acts on Na(v)1.5 by decreasing the channel density at the cell surface. The effect of Nedd4-2 requires the PY-motif of Nav1.5."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,15176425,"Observational study of genotype prevalence. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,15161528,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,15057319,"Mutations in the SCN5A gene encoding the cardiac voltage-gated Na+ channel (hNav1.5) are associated with Brugada syndrome."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,15051636,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,14985827,"Observational study of genotype prevalence. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,14961552,"Observational study of gene-disease association and genetic testing. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,14760488,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,14720472,"SCN5A the gene encoding the pore-forming subunit of the cardiac Na+ channel, have been associated with cardiac rhythm syndromes."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,14654377,"A base sequence deletion in SCN5A causes long QT syndrome in two family members."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,14500339,"Four variants of SCN5A are present in human myocardium and exhibit functional differences having implications for the choice of background sequence for experiments with heterologous expression systems, and possibly electrophysiological function in vivo"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,12820704,"missense mutations in KCNQ1 and SCN5A in a case of congenital Long QT Syndrome"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,12639704,"Another gene other than the SCN5A may be associated with Brugada syndrome."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,12574983,"Congenital long QT syndrome and 2:1 atrioventricular block may be due to mutation of the SCN5A gene (LQT3)."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,12569159,"SCN5A mutation is modulated by the SCN5a polymorphism in humans"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,12522116,"Familial Atrial standstill was associated with the concurrence of a cardiac sodium channel mutation and rare polymorphisms in the atrial-specific Cx40 gene"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,12471205,"SNP S1103Y in the cardiac sodium channel gene SCN5A is associated with cardiac arrhythmias and sudden death in a white family"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,12431447,"Early & late openings in cell-attached patches expressing human cardiac NaCh alpha-subunit & in ventricular cells of one normal & three failing human hearts showed that the late current is generated by a single population of channels in both."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,12429735,"regulation of gating by syntrophin gamma 2"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,12358675,"SCN5A is more widely distributed than previously thought and encodes the pore-forming alpha-subunit of the tetrodotoxin-resistant Na+ current in jejunum smooth muscle cells."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,12208804,"Drug-induced long-QT syndrome associated with a subclinical SCN5A mutation"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,12193783,"identified a variant of the cardiac sodium channel gene SCN5A that is associated with arrhythmia in African Americans and linked with arrhythmia risk in an African-American family"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,12106943,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,12106943,"Longer conduction intervals on baseline ECG were observed in patients with established SCN5A mutations. Brugada-syndrome patients with and without SCN5A mutations can be differentiated by phenotypical differences."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,12051963,"three new SCN5A mutations in Brugada syndrome patients are all located within domain I of SCN5A, a region not previously considered important in the development of ventricular arrhythmias"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,11997281,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,11960580,"Associated with Brugada syndrome, but patients may not have known mutation."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,11823453,"Mutation analysis seems to show SUNDS of Asia and Brugada syndrome of Europe are phenotypically and genetically the same."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,11786529,"Results support the concept that loss of function of the cardiac Na(+) channel is responsible for the Brugada syndrome."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,11748104,"A G-to-T mutation at position 4372 was identified by direct sequencing and was predicted to change a glycine for an arginine (G1406R) between the DIII-S5 and DIII-S6 domain of the SCN5A sodium channel protein."
https://pharos.nih.gov/idg/targets/Q14524,Q14524,11743032,"Observational study of gene-disease association, genetic testing, and healthcare-related. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,11289718,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q14524,Q14524,11136691,"Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q01118,Q01118,26537257,"The authors demonstrated that the sodium channel Nax functions as a sodium sensor.  With increased extracellular sodium, Nax up-regulates prostasin, which results in activation of the sodium channel ENaC."
https://pharos.nih.gov/idg/targets/Q01118,Q01118,25393565,"SNP rs7565062 of SCN7A was significantly associated with essential hypertension in a Northern Han Chinese population"
https://pharos.nih.gov/idg/targets/Q01118,Q01118,17339538,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q01118,Q01118,14669210,"Observational study of gene-disease association. (HuGE Navigator)"
